<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>Prognostic Reviews: Predicting Patient Futures</title>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Cormorant+Garamond:wght@400;600;700&amp;family=Source+Sans+Pro:wght@400;600&amp;display=swap" rel="stylesheet"/>
<style>
:root {
  --navy: #1E2761;
  --deep-navy: #141B3D;
  --gold: #D4AF37;
  --cream: #FAF8F5;
  --red: #BF2D2D;
  --teal: #2D8B8B;
  --light-text: #718096;
  --green: #2D8B5F;
  --purple: #6B46C1;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

body {
  font-family: 'Source Sans Pro', sans-serif;
  background: var(--cream);
  color: var(--navy);
  min-height: 100vh;
  display: flex;
}

.skip-link {
  position: absolute;
  top: -40px;
  left: 0;
  background: var(--gold);
  color: var(--navy);
  padding: 8px 16px;
  z-index: 1000;
  font-weight: 600;
  text-decoration: none;
  border-radius: 0 0 8px 0;
}

.skip-link:focus {
  top: 0;
}

.hamburger {
  display: none;
  position: fixed;
  top: 1rem;
  left: 1rem;
  z-index: 1001;
  background: var(--navy);
  border: none;
  border-radius: 8px;
  padding: 12px;
  cursor: pointer;
  flex-direction: column;
  gap: 4px;
}

.hamburger span {
  display: block;
  width: 24px;
  height: 3px;
  background: var(--gold);
  border-radius: 2px;
  transition: transform 0.3s;
}

.sidebar-overlay {
  display: none;
  position: fixed;
  inset: 0;
  background: rgba(0,0,0,0.5);
  z-index: 999;
}

.sidebar {
  width: 280px;
  background: var(--navy);
  padding: 2rem 1rem;
  display: flex;
  flex-direction: column;
  position: fixed;
  height: 100vh;
  overflow-y: auto;
  z-index: 1000;
}

.logo {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.3rem;
  color: var(--gold);
  margin-bottom: 0.5rem;
  text-align: center;
}

.tagline {
  font-size: 0.75rem;
  color: rgba(255,255,255,0.6);
  text-align: center;
  margin-bottom: 2rem;
  font-style: italic;
}

.nav-section {
  margin-bottom: 1.5rem;
}

.nav-label {
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 1px;
  color: rgba(255,255,255,0.4);
  margin-bottom: 0.75rem;
  padding-left: 0.5rem;
}

.module-item {
  display: flex;
  align-items: center;
  padding: 0.75rem;
  border-radius: 8px;
  cursor: pointer;
  transition: all 0.2s;
  margin-bottom: 0.25rem;
  border: none;
  background: transparent;
  width: 100%;
  text-align: left;
  font-family: inherit;
  font-size: inherit;
}

.module-item:hover {
  background: rgba(255,255,255,0.1);
}

.module-item.active {
  background: rgba(212, 175, 55, 0.2);
  border-left: 3px solid var(--gold);
}

.module-item.completed .module-number {
  background: var(--green);
}

.module-number {
  width: 28px;
  height: 28px;
  border-radius: 50%;
  background: rgba(255,255,255,0.2);
  display: flex;
  align-items: center;
  justify-content: center;
  font-size: 0.8rem;
  color: white;
  margin-right: 0.75rem;
  flex-shrink: 0;
}

.module-info {
  flex: 1;
  min-width: 0;
}

.module-title {
  font-size: 0.9rem;
  color: white;
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
}

.module-subtitle {
  font-size: 0.7rem;
  color: rgba(255,255,255,0.5);
}

.time-estimate {
  color: var(--teal);
  font-weight: 600;
  font-size: 0.65rem;
}

.main-content {
  flex: 1;
  margin-left: 280px;
  display: flex;
  flex-direction: column;
  min-height: 100vh;
}

.top-bar {
  display: flex;
  justify-content: space-between;
  align-items: center;
  padding: 1rem 2rem;
  background: white;
  border-bottom: 1px solid rgba(0,0,0,0.1);
  flex-wrap: wrap;
  gap: 1rem;
}

.progress-section {
  display: flex;
  align-items: center;
  gap: 1rem;
}

.progress-bar {
  width: 200px;
  height: 8px;
  background: rgba(0,0,0,0.1);
  border-radius: 4px;
  overflow: hidden;
}

.progress-fill {
  height: 100%;
  background: linear-gradient(90deg, var(--gold), var(--purple));
  border-radius: 4px;
  transition: width 0.3s;
}

.progress-text {
  font-size: 0.85rem;
  color: var(--light-text);
}

.course-time {
  font-size: 0.8rem;
  color: var(--light-text);
  padding: 0.25rem 0.75rem;
  background: rgba(107, 70, 193, 0.1);
  border-radius: 12px;
}

.points-display {
  display: flex;
  align-items: center;
  gap: 0.5rem;
  background: linear-gradient(135deg, var(--navy), #2a3a7d);
  color: var(--gold);
  padding: 0.5rem 1rem;
  border-radius: 20px;
  font-weight: 600;
}

.top-actions {
  display: flex;
  gap: 0.5rem;
}

.action-btn {
  padding: 0.5rem 1rem;
  border: 1px solid var(--navy);
  background: transparent;
  border-radius: 6px;
  cursor: pointer;
  font-size: 0.85rem;
  transition: all 0.2s;
}

.action-btn:hover {
  background: var(--navy);
  color: white;
}

.slide-container {
  flex: 1;
  padding: 2rem;
  max-width: 900px;
  margin: 0 auto;
  width: 100%;
}

.slide-title {
  text-align: center;
  padding: 4rem 2rem;
}

.slide-title h1 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 3rem;
  color: var(--navy);
  margin-bottom: 1rem;
}

.slide-title .subtitle {
  font-size: 1.5rem;
  color: var(--purple);
  margin-bottom: 1rem;
}

.slide-title .description {
  font-size: 1.1rem;
  color: var(--light-text);
  max-width: 600px;
  margin: 0 auto;
}

.principle-box {
  background: linear-gradient(135deg, var(--navy), #2a3a7d);
  border-radius: 16px;
  padding: 3rem;
  text-align: center;
  margin: 2rem 0;
}

.principle-box .number {
  font-size: 4rem;
  color: var(--gold);
  font-family: 'Cormorant Garamond', serif;
  line-height: 1;
}

.principle-box .text {
  font-size: 1.8rem;
  color: white;
  font-family: 'Cormorant Garamond', serif;
  margin-top: 1rem;
  font-style: italic;
}

.story-deep {
  background: linear-gradient(135deg, rgba(107,70,193,0.08), rgba(30,39,97,0.12));
  border-left: 4px solid var(--purple);
  border-radius: 0 16px 16px 0;
  padding: 1.5rem;
  margin: 1.5rem 0;
}

.story-label {
  font-size: 0.75rem;
  text-transform: uppercase;
  letter-spacing: 2px;
  color: var(--purple);
  margin-bottom: 0.5rem;
  font-weight: 600;
}

.story-source {
  font-size: 0.8rem;
  color: var(--light-text);
  margin-bottom: 1rem;
  font-style: italic;
}

.timeline {
  position: relative;
  padding-left: 2rem;
  margin: 1.5rem 0;
}

.timeline::before {
  content: '';
  position: absolute;
  left: 0.5rem;
  top: 0;
  bottom: 0;
  width: 2px;
  background: linear-gradient(to bottom, var(--gold), var(--purple), var(--green));
}

.timeline-event {
  position: relative;
  margin-bottom: 1rem;
  padding-left: 1rem;
}

.timeline-event::before {
  content: '';
  position: absolute;
  left: -1.5rem;
  top: 0.5rem;
  width: 10px;
  height: 10px;
  border-radius: 50%;
  background: var(--gold);
}

.timeline-event.crisis::before {
  background: var(--red);
}

.timeline-event.revelation::before {
  background: var(--green);
}

.timeline-year {
  font-weight: 600;
  color: var(--purple);
  font-size: 0.9rem;
}

.timeline-text {
  color: var(--navy);
  font-size: 0.95rem;
  margin-top: 0.25rem;
}

.real-data-box {
  background: rgba(45, 139, 139, 0.1);
  border-radius: 12px;
  padding: 1rem;
  margin-top: 1rem;
}

.real-data-box h4 {
  color: var(--teal);
  font-size: 0.85rem;
  margin-bottom: 0.75rem;
  text-transform: uppercase;
  letter-spacing: 1px;
}

.data-grid {
  display: grid;
  grid-template-columns: repeat(3, 1fr);
  gap: 0.75rem;
}

.data-item {
  text-align: center;
}

.data-label {
  font-size: 0.7rem;
  color: var(--light-text);
  text-transform: uppercase;
}

.data-value {
  font-size: 1rem;
  font-weight: 600;
  color: var(--navy);
}

.hook-text {
  background: linear-gradient(135deg, rgba(212,175,55,0.15), rgba(30,39,97,0.1));
  padding: 1rem;
  border-radius: 8px;
  margin-top: 1rem;
  font-style: italic;
  color: var(--navy);
}

.lesson-gold {
  color: var(--gold);
  font-weight: 600;
  font-style: normal;
  display: block;
  margin-top: 0.5rem;
  padding: 0.75rem;
  background: rgba(30,39,97,0.05);
  border-left: 3px solid var(--gold);
  border-radius: 0 8px 8px 0;
}

.content-box {
  background: white;
  border-radius: 16px;
  padding: 2rem;
  margin: 1.5rem 0;
  box-shadow: 0 2px 8px rgba(0,0,0,0.05);
}

.content-box h2 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.8rem;
  color: var(--navy);
  margin-bottom: 1.5rem;
}

.content-section {
  margin-bottom: 1.5rem;
}

.content-section:last-child {
  margin-bottom: 0;
}

.content-section h3 {
  color: var(--purple);
  font-size: 1.1rem;
  margin-bottom: 0.75rem;
}

.content-section ul {
  list-style: none;
  padding-left: 0;
}

.content-section li {
  padding: 0.5rem 0;
  padding-left: 1.5rem;
  position: relative;
  border-bottom: 1px solid rgba(0,0,0,0.05);
}

.content-section li:last-child {
  border-bottom: none;
}

.content-section li::before {
  content: '‚Üí';
  position: absolute;
  left: 0;
  color: var(--gold);
}

.content-section p {
  color: var(--navy);
  line-height: 1.6;
}

.method-box {
  background: linear-gradient(135deg, rgba(45,139,139,0.08), rgba(30,39,97,0.05));
  border-radius: 16px;
  padding: 2rem;
  margin: 1.5rem 0;
}

.method-label {
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 2px;
  color: var(--teal);
  margin-bottom: 0.5rem;
}

.method-box h2 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.6rem;
  color: var(--navy);
  margin-bottom: 1.5rem;
}

.method-section {
  margin-bottom: 1.25rem;
  padding-bottom: 1.25rem;
  border-bottom: 1px solid rgba(0,0,0,0.1);
}

.method-section:last-child {
  border-bottom: none;
  margin-bottom: 0;
  padding-bottom: 0;
}

.method-section h3 {
  color: var(--teal);
  font-size: 1rem;
  margin-bottom: 0.5rem;
}

.method-section p {
  color: var(--navy);
  line-height: 1.6;
  white-space: pre-line;
}

.decision-tree {
  background: white;
  border-radius: 16px;
  padding: 2rem;
  margin: 1.5rem 0;
  box-shadow: 0 4px 16px rgba(0,0,0,0.08);
}

.decision-tree h2 {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.6rem;
  color: var(--navy);
  margin-bottom: 0.5rem;
}

.decision-situation {
  background: rgba(107,70,193,0.1);
  padding: 1rem;
  border-radius: 8px;
  margin-bottom: 1.5rem;
  font-size: 0.95rem;
  color: var(--navy);
}

.decision-question {
  font-weight: 600;
  color: var(--purple);
  margin-bottom: 1rem;
  font-size: 1.1rem;
}

.decision-branches {
  display: flex;
  flex-direction: column;
  gap: 0.75rem;
}

.decision-branch {
  padding: 1rem;
  background: rgba(0,0,0,0.03);
  border: 2px solid transparent;
  border-radius: 8px;
  cursor: pointer;
  transition: all 0.2s;
  text-align: left;
  font-family: inherit;
  font-size: 0.95rem;
}

.decision-branch:hover {
  border-color: var(--purple);
  background: rgba(107,70,193,0.05);
}

.decision-outcome {
  padding: 1.5rem;
  border-radius: 12px;
  margin-top: 1rem;
}

.decision-outcome.success {
  background: linear-gradient(135deg, rgba(45,139,95,0.15), rgba(45,139,95,0.05));
  border-left: 4px solid var(--green);
}

.decision-outcome.danger {
  background: linear-gradient(135deg, rgba(191,45,45,0.15), rgba(191,45,45,0.05));
  border-left: 4px solid var(--red);
}

.decision-outcome.partial {
  background: linear-gradient(135deg, rgba(212,175,55,0.15), rgba(212,175,55,0.05));
  border-left: 4px solid var(--gold);
}

.outcome-title {
  font-weight: 600;
  font-size: 1.1rem;
  margin-bottom: 0.5rem;
}

.success .outcome-title { color: var(--green); }
.danger .outcome-title { color: var(--red); }
.partial .outcome-title { color: var(--gold); }

.outcome-text {
  color: var(--navy);
  margin-bottom: 1rem;
  line-height: 1.6;
}

.outcome-lesson {
  font-style: italic;
  color: var(--light-text);
  padding-top: 0.75rem;
  border-top: 1px solid rgba(0,0,0,0.1);
}

.tree-controls {
  display: flex;
  gap: 0.5rem;
  margin-top: 1rem;
}

.tree-btn {
  padding: 0.5rem 1rem;
  border: 1px solid var(--navy);
  background: transparent;
  border-radius: 6px;
  cursor: pointer;
  font-size: 0.85rem;
  transition: all 0.2s;
}

.tree-btn:hover {
  background: var(--navy);
  color: white;
}

.quiz-container {
  background: white;
  border-radius: 16px;
  padding: 2rem;
  margin: 1.5rem 0;
  box-shadow: 0 4px 16px rgba(0,0,0,0.08);
}

.quiz-question {
  font-size: 1.1rem;
  color: var(--navy);
  margin-bottom: 1.5rem;
  font-weight: 500;
}

.quiz-options {
  display: flex;
  flex-direction: column;
  gap: 0.75rem;
}

.quiz-option {
  padding: 1rem;
  background: rgba(0,0,0,0.03);
  border: 2px solid transparent;
  border-radius: 8px;
  cursor: pointer;
  transition: all 0.2s;
  text-align: left;
  font-family: inherit;
  font-size: 0.95rem;
}

.quiz-option:hover {
  border-color: var(--purple);
}

.quiz-option.selected {
  border-color: var(--navy);
  background: rgba(30,39,97,0.05);
}

.quiz-option.correct {
  border-color: var(--green);
  background: rgba(45,139,95,0.1);
}

.quiz-option.incorrect {
  border-color: var(--red);
  background: rgba(191,45,45,0.1);
}

.quiz-feedback {
  margin-top: 1rem;
  padding: 1rem;
  border-radius: 8px;
  display: none;
}

.quiz-feedback.show {
  display: block;
}

.quiz-feedback.correct {
  background: rgba(45,139,95,0.1);
  border-left: 4px solid var(--green);
}

.quiz-feedback.incorrect {
  background: rgba(191,45,45,0.1);
  border-left: 4px solid var(--red);
}

.nav-buttons {
  display: flex;
  justify-content: space-between;
  padding: 1rem 2rem;
  background: white;
  border-top: 1px solid rgba(0,0,0,0.1);
}

.nav-btn {
  display: flex;
  align-items: center;
  gap: 0.5rem;
  padding: 0.75rem 1.5rem;
  border: none;
  border-radius: 8px;
  cursor: pointer;
  font-size: 1rem;
  font-weight: 600;
  transition: all 0.2s;
}

.nav-btn.prev {
  background: rgba(0,0,0,0.05);
  color: var(--navy);
}

.nav-btn.prev:hover {
  background: rgba(0,0,0,0.1);
}

.nav-btn.next {
  background: linear-gradient(135deg, var(--purple), #8B5CF6);
  color: white;
}

.nav-btn.next:hover {
  transform: translateX(4px);
}

.nav-btn:disabled {
  opacity: 0.5;
  cursor: not-allowed;
}

.badge-notification {
  position: fixed;
  bottom: 2rem;
  right: 2rem;
  background: linear-gradient(135deg, var(--navy), #2a3a7d);
  border-radius: 16px;
  padding: 1rem 1.5rem;
  display: flex;
  align-items: center;
  gap: 1rem;
  box-shadow: 0 8px 32px rgba(0,0,0,0.3);
  z-index: 3000;
  transform: translateY(100px);
  opacity: 0;
  transition: all 0.5s cubic-bezier(0.34, 1.56, 0.64, 1);
}

.badge-notification.show {
  transform: translateY(0);
  opacity: 1;
}

.badge-icon {
  width: 48px;
  height: 48px;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-size: 1.5rem;
  box-shadow: 0 4px 12px rgba(0,0,0,0.2);
}

.badge-info {
  color: white;
}

.badge-earned {
  font-size: 0.7rem;
  text-transform: uppercase;
  letter-spacing: 1px;
  color: var(--gold);
  margin-bottom: 0.25rem;
}

.badge-name {
  font-family: 'Cormorant Garamond', serif;
  font-size: 1.2rem;
  font-weight: 600;
}

.badge-grid {
  display: grid;
  grid-template-columns: repeat(auto-fill, minmax(140px, 1fr));
  gap: 1rem;
  margin-top: 1rem;
}

.badge-card {
  background: white;
  border-radius: 12px;
  padding: 1rem;
  text-align: center;
  border: 2px solid transparent;
  transition: all 0.3s;
}

.badge-card.earned {
  border-color: var(--gold);
  box-shadow: 0 4px 12px rgba(212, 175, 55, 0.2);
}

.badge-card.locked {
  opacity: 0.5;
  filter: grayscale(1);
}

.formula-box {
  background: rgba(30, 39, 97, 0.08);
  border-radius: 8px;
  padding: 1rem;
  margin: 1rem 0;
  font-family: 'Courier New', monospace;
  text-align: center;
  color: var(--navy);
  font-size: 1.1rem;
}

.performance-metric {
  display: flex;
  align-items: center;
  gap: 1rem;
  padding: 1rem;
  background: rgba(107, 70, 193, 0.08);
  border-radius: 8px;
  margin: 0.75rem 0;
}

.metric-value {
  font-size: 2rem;
  font-weight: 700;
  color: var(--purple);
  min-width: 80px;
  text-align: center;
}

.metric-info h4 {
  color: var(--navy);
  margin-bottom: 0.25rem;
}

.metric-info p {
  font-size: 0.85rem;
  color: var(--light-text);
}

@media (max-width: 768px) {
  .hamburger {
    display: flex;
  }

  .sidebar {
    transform: translateX(-100%);
    transition: transform 0.3s;
  }

  .sidebar.open {
    transform: translateX(0);
  }

  .sidebar-overlay.show {
    display: block;
  }

  .main-content {
    margin-left: 0;
  }

  .slide-title h1 {
    font-size: 2rem;
  }

  .data-grid {
    grid-template-columns: 1fr 1fr;
  }

  .top-bar {
    padding: 1rem;
  }

  .progress-bar {
    width: 120px;
  }
}

@media (max-width: 480px) {
  .sidebar {
    width: 100%;
  }

  .slide-container {
    padding: 1rem;
  }

  .story-deep, .method-box, .content-box {
    padding: 1rem;
  }

  .data-grid {
    grid-template-columns: 1fr 1fr;
  }

  .top-actions {
    width: 100%;
    justify-content: center;
  }
}

    /* Focus-visible styles for keyboard navigation */
    :focus-visible {
      outline: 2px solid var(--gold, #D4AF37);
      outline-offset: 2px;
    }

    :focus:not(:focus-visible) {
      outline: none;
    }

    button:focus-visible,
    a:focus-visible,
    [role="button"]:focus-visible,
    input:focus-visible,
    select:focus-visible,
    textarea:focus-visible {
      outline: 2px solid var(--gold, #D4AF37);
      outline-offset: 2px;
      box-shadow: 0 0 0 4px rgba(212, 175, 55, 0.3);
    }

    /* Screen Reader Only */
    .sr-only {
      position: absolute;
      width: 1px;
      height: 1px;
      padding: 0;
      margin: -1px;
      overflow: hidden;
      clip: rect(0, 0, 0, 0);
      white-space: nowrap;
      border: 0;
    }

    @media (prefers-reduced-motion: reduce) {
      *, *::before, *::after {
        animation-duration: 0.01ms !important;
        animation-iteration-count: 1 !important;
        transition-duration: 0.01ms !important;
        scroll-behavior: auto !important;
      }
    }
  </style>
</head>
<body>
<a class="skip-link" href="#main-content">Skip to main content</a>
<button aria-expanded="false" aria-label="Toggle navigation menu" class="hamburger">
<span></span>
<span></span>
<span></span>
</button>
<div class="sidebar-overlay"></div>
<nav aria-label="Modules du cours" class="sidebar" role="navigation">
<a href="index.html" onmouseout="this.style.color='rgba(212,175,55,0.7)'" onmouseover="this.style.color='#D4AF37'" style="display:block;font-size:0.7rem;color:rgba(212,175,55,0.7);text-decoration:none;margin-bottom:0.5rem;padding:0.5rem 1rem 0;">‚Üê Course Library</a>
<div class="logo">Prognostic Reviews</div>
<div class="tagline">Predicting Patient Futures</div>
<div class="nav-section">
<div class="nav-label">Modules</div>
<div id="module-nav"></div>
</div>
</nav>
<main class="main-content" id="main-content">
<div class="top-bar">
<div class="progress-section">
<div class="progress-bar">
<div class="progress-fill" id="progress-fill" style="width: 0%"></div>
</div>
<span class="progress-text" id="progress-text">0% Complete</span>
</div>
<div class="course-time">
<span id="total-time">5h 40m total</span>
</div>
<div class="points-display">
<span id="points-display">0</span> XP
      </div>
<div class="top-actions">
<button class="action-btn" onclick="openBadges()">üèÜ Badges</button>
<button class="action-btn" onclick="openGlossary()">Glossary</button>
</div>
</div>
<div class="slide-container" id="slide-container"></div>
<div aria-live="polite" class="sr-only" id="slide-announce"></div>
<div class="nav-buttons">
<button class="nav-btn prev" id="prev-btn" onclick="prevSlide()">
<span>‚Üê</span> Previous
      </button>
<button class="nav-btn next" id="next-btn" onclick="nextSlide()">
        Next <span>‚Üí</span>
</button>
</div>
</main>
<script>
const STORAGE_KEY = 'prognostic-reviews-course-progress';

let currentModule = 0;
let currentSlide = 0;
let gameState = {
  points: 0,
  earnedBadges: [],
  modulesCompleted: [],
  decisionTrees: {}
};

// Badge Definitions
const BADGES = {
  'model-builder': { name: 'Model Builder', icon: 'üîß', color: '#6B46C1', requirement: 'Module complet de d√©veloppement de mod√®les' },
  'validation-expert': { name: 'Validation Expert', icon: '‚úÖ', color: '#2D8B5F', requirement: 'Module complet de validation' },
  'calibration-master': { name: 'Calibration Master', icon: 'üìä', color: '#2D8B8B', requirement: 'Exercices d\'√©talonnage complets' },
  'tripod-scholar': { name: 'TRIPOD Scholar', icon: 'üìù', color: '#D4AF37', requirement: 'Module complet de reporting' },
  'decision-analyst': { name: 'Decision Analyst', icon: 'üìà', color: '#BF2D2D', requirement: 'Module complet de courbes de d√©cision' },
  'story-collector': { name: 'Story Collector', icon: 'üìö', color: '#1e2761', requirement: 'Lire tous les cas √©tudes' },
  'tree-navigator': { name: 'Tree Navigator', icon: 'üå≥', color: '#2D8B5F', requirement: 'Compl√©tez 15 arbres de d√©cision' },
  'prognosis-master': { name: 'Prognosis Master', icon: 'üéì', color: '#6B46C1', requirement: 'Compl√©tez l\'int√©gralit√© cours' },
  'penalization-pro': { name: 'Penalization Pro', icon: 'üéØ', color: '#8B5CF6', requirement: 'Master LASSO/Ridge content' },
  'communicator': { name: 'Patient Communicator', icon: 'üí¨', color: '#EC4899', requirement: 'Learn uncertainty communication' },
  'skeptic': { name: 'AI Skeptic', icon: 'ü§ñ', color: '#F59E0B', requirement: 'Module complet de ML vs r√©gression' },
  'implementer': { name: 'Implementation Expert', icon: 'üè•', color: '#10B981', requirement: 'Module de mise en ≈ìuvre complet' }
};

const modules = [
  {
    id: 0,
    title: "The Opening",
    subtitle: "Why Prognosis Matters",
    principle: null,
    estimatedTime: "15 min",
    slides: [
      {
        type: 'title',
        content: {
          title: "Prognostic Reviews",
          subtitle: "Predicting Patient Futures",
          text: "Apprenez √† √©valuer et √† cr√©er des mod√®les de pr√©diction √† travers les histoires de scores qui ont sauv√© des vies et d'algorithmes qui promettaient trop."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "LA FONDATION¬†: FRAMINGHAM ‚Äî WHEN LES M√âDECINS APPRIS √Ä VOIR L'AVENIR",
          source: "Framingham Heart Study 1948-present | Wilson 1998 | Circulation",
          timeline: [
            { year: "1948", text: "Framingham Heart Study begins in Massachusetts. 5,209 adults enrolled. No one knows what causes heart disease. Cholesterol is just a chemical.", type: "normal" },
            { year: "1961", text: "First major finding: high cholesterol, high blood pressure, and smoking predict heart attacks. The concept of 'risk factors' is born.", type: "revelation" },
            { year: "1976", text: "Framingham Risk Score developed: age, sex, cholesterol, BP, smoking, diabetes combined into one number. Doctors can now QUANTIFY a patient's 10-year risk.", type: "revelation" },
            { year: "1998", text: "Updated Framingham Risk Score published. C-statistic 0.76-0.79. Widely adopted. Millions of statin decisions based on this score.", type: "normal" },
            { year: "2000s", text: "External validation shows Framingham overestimates risk in some populations (UK, Europe, Asia). Recalibration needed. One model doesn't fit all.", type: "crisis" },
            { year: "Legacy", text: "Framingham proved prognosis is POSSIBLE and USEFUL. But it also showed: models must be validated, calibration matters, and context is everything.", type: "revelation" }
          ],
          realData: {
            endpoint: "10-year cardiovascular disease risk",
            model: "Framingham Risk Score",
            discrimination: "C-statistic 0.76-0.79",
            impact: "Guides statin therapy for millions worldwide"
          },
          hook: "THE HOOK: Before Framingham, doctors guessed who would have heart attacks. After Framingham, they could calculate it. This course teaches you to evaluate such calculations ‚Äî to know when a prognostic model helps patients and when it's just mathematical theater."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è KEY INSIGHT: Prognostic models translate uncertainty into numbers. A patient asking 'What are my chances?' deserves more than 'It depends.' But those numbers must be ACCURATE (calibration), DISCRIMINATING (separate high from low risk), and USEFUL (change decisions). A model can fail any of these ‚Äî and often does."
        }
      },
      {
        type: 'content',
        content: {
          title: "What Is Prognostic Research?",
          sections: [
            {
              heading: "Prognosis vs Other Research Types:",
              items: [
                "DIAGNOSTIC: Who HAS the disease NOW? (presence/absence)",
                "ETIOLOGIC: What CAUSES the disease? (causation)",
                "THERAPEUTIC: What TREATS the disease? (intervention effects)",
                "PROGNOSTIC: What WILL HAPPEN to the patient? (future outcomes)"
              ]
            },
            {
              heading: "Why Prognosis Matters:",
              items: [
                "Treatment decisions: Should this patient get aggressive therapy?",
                "Patient counseling: What should I expect?",
                "Resource allocation: Who needs intensive monitoring?",
                "Trial design: Enriching populations for higher event rates",
                "Quality measurement: Risk-adjusted outcomes"
              ]
            },
            {
              heading: "The Fundamental Question:",
              text: "Compte tenu de ce que nous savons MAINTENANT sur un patient, quelle est la probabilit√© d'un R√âSULTAT sp√©cifique dans un HORIZON TEMPS d√©fini¬†?"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "The Seven Principles of Prognostic Modeling",
          sections: [
            {
              heading: "Your Guide Through This Course:",
              items: [
                "1. \\\"La pr√©diction n'est pas une causalit√©\\\" ‚Äî Les pr√©dicteurs ne doivent pas n√©cessairement √™tre des causes",
                "2. \"A model is only as good as its validation\" ‚Äî Development means nothing without testing",
                "3. \"Discrimination is not enough\" ‚Äî A model must also be calibrated",
                "4. \"More predictors is not better\" ‚Äî Overfitting destroys generalizability",
                "5. \\\"La population d√©finit la pr√©diction\\\" ‚Äî Les mod√®les ne voyagent pas librement",
                "6. \"Clinical utility trumps statistics\" ‚Äî Good numbers don't guarantee good decisions",
                "7. \"Transparency enables trust\" ‚Äî TRIPOD and reporting standards matter"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'prognosis-vs-diagnosis',
          title: "Prognosis or Diagnosis?",
          situation: "Classify each clinical question as prognostic, diagnostic, etiologic, or therapeutic.",
          nodes: {
            start: {
              question: "QUESTION 1 : 'Ce patient souffrant de douleurs thoraciques a-t-il une embolie pulmonaire ?'",
              branches: [
                { text: "Prognostic ‚Äî predicting future outcome", nextNode: "q1_wrong" },
                { text: "Diagnostic ‚Äî determining current disease state", nextNode: "q1_correct" }
              ]
            },
            q1_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "This is diagnostic!",
              text: "The question is about what the patient HAS right now (PE or not), not what will happen in the future. Diagnosis = current state. Prognosis = future outcome.",
              lesson: "Questions de diagnostic : Le patient A-t-il la condition X¬†? Questions pronostiques¬†: Qu'arrivera-t-il au patient¬†?"
            },
            q1_correct: {
              situation: "Correct¬†! La question porte sur l'√©tat actuel de la maladie, et non sur les r√©sultats futurs.",
              question: "QUESTION 2¬†: ¬´¬†Quelle est la probabilit√© de survie de ce patient en soins intensifs jusqu'√† sa sortie de l'h√¥pital¬†?¬†¬ª",
              branches: [
                { text: "Prognostic ‚Äî predicting future survival", nextNode: "q2_correct" },
                { text: "Diagnostic ‚Äî assessing current severity", nextNode: "q2_wrong" }
              ]
            },
            q2_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Proche, mais il s'agit d'un pronostic",
              text: "Bien que l'√©valuation de la gravit√© puisse √©clairer la pr√©diction, la QUESTION concerne un r√©sultat FUTUR. (survie jusqu'√† la d√©charge). L'horizon temporel rend le pronostic.",
              lesson: "Si la question implique un moment futur (survivra, se d√©veloppera, se reproduira), c'est un pronostic."
            },
            q2_correct: {
              situation: "Correct! Survival to discharge is a future outcome ‚Äî classic prognosis.",
              question: "QUESTION 3: 'Does smoking cause lung cancer?'",
              branches: [
                { text: "Prognostic ‚Äî smoking predicts cancer", nextNode: "q3_prog_wrong" },
                { text: "√âtiologique¬†: poser des questions sur la causalit√©", nextNode: "q3_correct" }
              ]
            },
            q3_prog_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Le tabagisme EST pr√©dictif, mais ce n'est pas le cas. question",
              text: "Le tabagisme pr√©dit le cancer du poumon et pourrait faire partie d'un mod√®le pronostique. Mais la question est de savoir si le tabagisme CAUSE le cancer ‚Äì c'est √©tiologique. Le pronostic utilise des pr√©dicteurs quelle que soit la cause.",
              lesson: "Prognostic models can include non-causal predictors. Etiologic research specifically asks about CAUSATION."
            },
            q3_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Exactly right!",
              text: "La question concerne la CAUSATION¬†: le tabagisme provoque-t-il le cancer¬†? Cela n√©cessite des m√©thodes d‚Äôinf√©rence causale (contr√¥le confondant, temporalit√©, etc.). Les mod√®les pronostiques peuvent utiliser le tabagisme comme pr√©dicteur SANS prouver son lien de causalit√©.",
              lesson: "Prediction ‚â† Causation. A prognostic model can include age, sex, biomarkers ‚Äî none 'cause' the outcome, but all predict it."
            }
          }
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: As you learn prognostic methods, remember: every model is wrong, but some are useful. Framingham changed medicine. But poorly validated models have also caused harm ‚Äî allocating resources wrongly, giving false reassurance, or creating false alarm. The question isn't whether a model exists, but whether it WORKS and HELPS."
        }
      }
    ]
  },
  {
    id: 1,
    title: "The Factors",
    subtitle: "√âtudes sur les facteurs pronostiques",
    principle: 0,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "La pr√©diction n'est pas une causalit√©"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE BIOMARKER TRAP: TROPONIN ‚Äî WHEN A PREDICTOR BECAME A TARGET",
          source: "Multiple troponin trials | JAMA, NEJM | High-sensitivity assays",
          timeline: [
            { year: "1990s", text: "Cardiac troponin identified as marker of myocardial damage. Elevated troponin strongly predicts death in ACS patients. OR for death: 3-5x.", type: "normal" },
            { year: "2000s", text: "Troponin becomes standard for ACS diagnosis AND prognosis. Higher levels = worse outcomes. Dose-response relationship clear.", type: "normal" },
            { year: "The Idea", text: "'If high troponin predicts bad outcomes, we should treat patients with high troponin more aggressively.' Trials test intensive therapy in troponin-positive patients.", type: "normal" },
            { year: "The Results", text: "FRISC-II, TACTICS-TIMI 18: Invasive strategy helps troponin-positive patients. Success? Or just treating sicker patients?", type: "revelation" },
            { year: "The Trap", text: "La troponine PR√âDIT les r√©sultats, mais ne les CAUSE pas. R√©duire la troponine (le nombre) n‚Äôam√©liore pas les r√©sultats. La troponine est un MARQUEUR de dommage, pas une cible de traitement.", type: "crisis" },
            { year: "Lesson", text: "Les facteurs pronostiques peuvent guider QUELS patients doivent traiter de mani√®re intensive. Mais traiter LE FACTEUR (diminuer le nombre) n'aide pas √† moins que le facteur soit causal ET modifiable.", type: "revelation" }
          ],
          realData: {
            endpoint: "Mortality, reinfarction",
            factor: "Troponin elevation",
            effect: "OR 3-5 pour les r√©sultats ind√©sirables",
            lesson: "Predicts outcome; not a treatment target"
          },
          hook: "THE HOOK: Troponin is a superb prognostic factor. But trying to 'lower troponin' makes no sense ‚Äî it's smoke, not fire. The first principle of prognostic factors: PREDICTION does not equal CAUSATION. A factor can be a perfect predictor and a useless treatment target."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è APER√áU CL√â¬†: Les facteurs pronostiques sont des variables associ√©es aux r√©sultats futurs. Ils n‚Äôont pas besoin d‚Äô√™tre CAUSAUX. L'√¢ge pr√©dit la mortalit√©, mais vous ne pouvez pas changer l'√¢ge. Les marqueurs tumoraux pr√©disent la r√©cidive, mais leur diminution ne gu√©rit pas le cancer. Distinguer les facteurs PROGNOSTIQUES des cibles TH√âRAPEUTIQUES."
        }
      },
      {
        type: 'content',
        content: {
          title: "Qu'est-ce qu'une √©tude de facteurs pronostiques¬†?",
          sections: [
            {
              heading: "Definition:",
              items: [
                "√âtude examinant si un facteur est associ√© √† un r√©sultat clinique",
                "Usually in patients with a specific condition (inception cohort)",
                "Factor measured at baseline; outcome measured later",
                "Adjust for other known prognostic factors to assess INDEPENDENT contribution"
              ]
            },
            {
              heading: "Types of Prognostic Factors:",
              items: [
                "DEMOGRAPHIC: Age, sex, race/ethnicity",
                "CLINICAL: Disease stage, comorbidities, functional status",
                "BIOMARKERS: Lab values, imaging findings, genetic markers",
                "PATIENT-REPORTED: Quality of life, symptoms, preferences"
              ]
            },
            {
              heading: "Key Distinction:",
              text: "Facteur pronostique ‚â† Facteur de risque. Les facteurs de risque sont √©tudi√©s dans des populations saines (qui d√©veloppe la maladie ?). Les facteurs pronostiques sont √©tudi√©s chez les patients atteints de la maladie (que leur arrive-t-il¬†?)."
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "LA M√âTHODE¬†: CONCEPTION DE L'√âTUDE DES FACTEURS PRONOSTIQUE",
          title: "Comment √©tudier les facteurs pronostiques",
          sections: [
            {
              heading: "1. Define the Population (Inception Cohort):",
              text: "‚Ä¢ Start point: Diagnosis, treatment initiation, or clinical event\n‚Ä¢ All patients should be at SIMILAR point in disease course\n‚Ä¢ Avoid prevalent cohorts (survivors already selected)"
            },
            {
              heading: "2. Measure the Factor at Baseline:",
              text: "‚Ä¢ Before outcome can occur\n‚Ä¢ Standardized measurement\n‚Ä¢ Handle missing data transparently"
            },
            {
              heading: "3. Define the Outcome:",
              text: "‚Ä¢ Clinically meaningful (death, recurrence, functional status)\n‚Ä¢ Fixed time horizon (5-year survival, 30-day readmission)\n‚Ä¢ Objective measurement or adjudication"
            },
            {
              heading: "4. Adjust for Confounders:",
              text: "‚Ä¢ Autres facteurs pronostiques √©tablis ‚Ä¢ Variables pouvant expliquer l'association ‚Ä¢ Utiliser les DAG pour identifier l'ajustement ensembles"
            },
            {
              heading: "5. Report Effect Sizes with Uncertainty:",
              text: "‚Ä¢ Hazard ratios, odds ratios, or risk ratios with 95% CIs\n‚Ä¢ Continuous factors: per-unit change or meaningful increments\n‚Ä¢ Avoid arbitrary dichotomization"
            }
          ]
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE FALSE PROMISE: PSA VELOCITY ‚Äî WHEN A PROGNOSTIC FACTOR WASN'T",
          source: "Vickers et al. JNCI 2011 | PSA velocity meta-analysis | Prostate cancer",
          timeline: [
            { year: "1990s", text: "PSA velocity (rate of PSA rise) proposed as prostate cancer predictor. Faster rise = more aggressive cancer. Made biological sense.", type: "normal" },
            { year: "2000s", text: "Des √©tudes d'observation montrent que la vitesse du PSA pr√©dit la mortalit√©. Les lignes directrices int√®grent la vitesse dans les d√©cisions de biopsie. Des parcours cliniques entiers construits autour de lui.", type: "normal" },
            { year: "2007", text: "Systematic review by Vickers: When ADJUSTING FOR BASELINE PSA, velocity adds NO prognostic information. Velocity was confounded by baseline level.", type: "crisis" },
            { year: "The Math", text: "High velocity often means high PSA. High PSA predicts outcomes. Velocity appeared predictive only because it correlated with level. Classic confounding.", type: "revelation" },
            { year: "Aftermath", text: "Guidelines revised. Velocity de-emphasized. Years of clinical practice based on a 'prognostic factor' that wasn't independently prognostic.", type: "crisis" },
            { year: "Lesson", text: "Demandez-vous toujours¬†: ce facteur ajoute-t-il des informations AU-DEL√Ä de ce que nous savons d√©j√†¬†? Une valeur pronostique ind√©pendante n√©cessite un ajustement en fonction des facteurs √©tablis.", type: "revelation" }
          ],
          realData: {
            endpoint: "Prostate cancer mortality",
            factor: "PSA velocity (unadjusted)",
            effect: "HR ~2,0 pour les valeurs √©lev√©es et faibles",
            adjusted: "HR ~1.0 when adjusted for baseline PSA"
          },
          hook: "THE HOOK: PSA velocity was used for years before anyone checked if it added information beyond baseline PSA. It didn't. The lesson: A factor that CORRELATES with the outcome isn't necessarily an INDEPENDENT prognostic factor. Always adjust for what you already know."
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'prognostic-factor-assessment',
          title: "Ce facteur est-il vraiment pronostique¬†?",
          situation: "A study claims that serum ferritin predicts mortality in heart failure patients. HR 2.1 (95% CI 1.5-2.9) for high vs low ferritin. The study adjusted for age and sex only. Known prognostic factors in heart failure include: ejection fraction, BNP, renal function, NYHA class.",
          nodes: {
            start: {
              question: "Quelle est votre premi√®re pr√©occupation √† propos de cette √©tude¬†?",
              branches: [
                { text: "Le HR de 2,1 est trop √©lev√© pour √™tre cr√©dible", nextNode: "hr_concern" },
                { text: "L'ajustement pour l'√¢ge et le sexe uniquement est insuffisant", nextNode: "adjustment_correct" },
                { text: "Ferritin isn't biologically plausible", nextNode: "biology_concern" }
              ]
            },
            hr_concern: {
              type: 'outcome',
              outcome: 'partial',
              title: "HR 2.1 isn't inherently implausible",
              text: "Des tailles d'effet de 2,0 sont courantes pour les facteurs pronostiques forts (troponine, BNP). Le probl√®me n'est pas l'ampleur de l'effet, mais plut√¥t sa persistance apr√®s un ajustement appropri√©. Un facteur avec HR 2,0 non ajust√© pourrait avoir HR 1,0 ajust√©.",
              lesson: "Judge prognostic factors by their adjusted effects, not by whether raw effects 'seem' too big."
            },
            adjustment_correct: {
              situation: "Exactement¬†! Sans ajustement en fonction de la FE, du BNP, de la fonction r√©nale et de la classe NYHA, nous ne savons pas si la ferritine est IND√âPENDAMMENT pronostique ou si elle est simplement corr√©l√©e √† ces facteurs √©tablis.",
              question: "Une nouvelle analyse s'ajuste √† tous les principaux facteurs. Ferritine HR passe de 2,1 √† 1,3 (0,95-1,7). Que concluez-vous¬†?",
              branches: [
                { text: "Ferritin is still prognostic ‚Äî HR > 1.0", nextNode: "still_prognostic_wrong" },
                { text: "Ferritin adds minimal independent information ‚Äî CI includes 1.0", nextNode: "minimal_info_correct" },
                { text: "L'√©tude √©tait fausse ‚Äî la ferritine est inutile", nextNode: "useless_too_strong" }
              ]
            },
            biology_concern: {
              type: 'outcome',
              outcome: 'partial',
              title: "Biology matters, but don't require it",
              text: "Biological plausibility strengthens causal claims. But prognostic factors don't need to be causal! Age predicts mortality without 'causing' it. Ferritin could be a marker of inflammation, iron status, or comorbidity ‚Äî any of which might explain prediction.",
              lesson: "Pour le PROGNOSTIC¬†: la plausibilit√© est agr√©able mais pas obligatoire. Pour l'√âTIOLOGIE¬†: la plausibilit√© est essentielle."
            },
            still_prognostic_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Regardez l'intervalle de confiance¬†!",
              text: "HR 1,3 avec IC √† 95¬†% 0,95-1,7 COMPREND 1,0. Cela signifie que nous ne pouvons exclure aucune association. L'estimation ponctuelle a chut√© de 60 % apr√®s ajustement (de 2,1 √† 1,3), ce qui sugg√®re que la majeure partie de ¬´ l'effet ¬ª √©tait confondue.",
              lesson: "Always report and interpret confidence intervals. A point estimate means nothing without uncertainty."
            },
            minimal_info_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct interpretation!",
              text: "L'att√©nuation de 60 % (2,1 ‚Üí 1,3) sugg√®re que la ferritine captait en grande partie la variation d'autres facteurs (probablement la fonction r√©nale et l'inflammation). Le CI inclut d√©sormais la version 1.0. La ferritine ajoute probablement peu d'informations pronostiques ind√©pendantes dans l'insuffisance cardiaque.",
              lesson: "This pattern (strong unadjusted, weak adjusted) is extremely common. Always demand properly adjusted analyses before accepting a 'new prognostic factor.'"
            },
            useless_too_strong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Too strong a conclusion",
              text: "The adjusted HR is 1.3 ‚Äî not 1.0. Ferritin MIGHT have modest independent prognostic value; we're just uncertain. It's not 'useless' ‚Äî it's 'not proven useful beyond existing factors.' A larger study might clarify.",
              lesson: "Absence de preuve ‚â† preuve d'absence. Mais nous ne devrions pas utiliser de facteurs cliniquement tant qu'une valeur pronostique ind√©pendante n'est pas √©tablie."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A biomarker strongly predicts mortality (HR 4.0, p<0.001) but is NOT on the causal pathway to death. This biomarker could still be useful for:",
          options: [
            { id: 'a', text: "D√©velopper un traitement qui abaisse le biomarqueur", correct: false },
            { id: 'b', text: "Risk stratification to guide treatment intensity", correct: true },
            { id: 'c', text: "Prouver que le biomarqueur provoque la mort", correct: false },
            { id: 'd', text: "Replacing other prognostic factors in clinical assessment", correct: false }
          ],
          explanation: "Les pr√©dicteurs non causals sont inutiles en tant que cibles de traitement (les abaisser n'aidera pas) mais PEUVENT √™tre utiles pour le risque stratification. Si un biomarqueur identifie des patients √† haut risque, les cliniciens peuvent traiter ces patients de mani√®re plus agressive, m√™me si le biomarqueur lui-m√™me n'est pas la cible du traitement."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE PSA SCREENING CONTROVERSY ‚Äî EXCELLENT DISCRIMINATION, TERRIBLE UTILITY",
          source: "US Preventive Services Task Force | ERSPC Trial | Prostate cancer screening debates",
          timeline: [
            { year: "1986", text: "L'antig√®ne sp√©cifique de la prostate (PSA) est approuv√© par la FDA pour la surveillance du cancer de la prostate. Bient√¥t adopt√© pour le D√âPISTAGE des hommes en bonne sant√©. La logique¬†: un taux de PSA √©lev√© pr√©dit le cancer de la prostate.", type: "normal" },
            { year: "1990s", text: "PSA screening becomes routine. Millions of men tested annually. Prostate cancer diagnoses skyrocket. 'Early detection saves lives' becomes dogma.", type: "normal" },
            { year: "The Problem", text: "PSA is elevated in prostate cancer ‚Äî but also in benign prostatic hyperplasia, prostatitis, even vigorous cycling. PSA discriminates cancer from no-cancer... imperfectly.", type: "crisis" },
            { year: "Overdiagnosis", text: "Many detected cancers would NEVER have caused symptoms or death. These indolent tumors were treated anyway: surgery, radiation, hormones. Men suffered incontinence, impotence, anxiety ‚Äî for cancers that didn't need treatment.", type: "crisis" },
            { year: "2012", text: "USPSTF recommande CONTRE le d√©pistage syst√©matique du PSA. Les inconv√©nients (surdiagnostic, surtraitement) l‚Äôemportaient sur les avantages. Un facteur pronostique avec une excellente discrimination mais un pr√©judice clinique net.", type: "revelation" },
            { year: "Lesson", text: "PSA correctly identifies men with prostate cancer. But not all prostate cancers are equal. Detecting harmless cancers and treating them aggressively causes MORE harm than missing them. <span class='lesson-gold'>THE LESSON: A prognostic factor can have excellent discrimination yet terrible clinical utility. The question isn't just 'does it predict?' but 'does acting on the prediction help patients?'</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "Prostate cancer detection",
            factor: "PSA (prostate-specific antigen)",
            discrimination: "Statistique C ~0,70 pour la d√©tection du cancer",
            problem: "Overdiagnosis and overtreatment of indolent cancers"
          },
          hook: "THE HOOK: PSA is the canonical example of a good prognostic factor that causes harm in practice. It PREDICTS prostate cancer. The prediction is ACCURATE. But acting on that prediction ‚Äî biopsying, treating, worrying ‚Äî often hurts men more than the cancer would have. Clinical utility requires more than accurate prediction."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You now understand prognostic factor studies. Key lessons: (1) Factors must be independently predictive after adjustment; (2) Prediction ‚â† causation; (3) Unadjusted associations are often confounded; (4) Non-causal predictors can still guide treatment decisions by identifying high-risk patients."
        }
      }
    ]
  },
  {
    id: 2,
    title: "The Models",
    subtitle: "Prediction Model Development",
    principle: 1,
    estimatedTime: "40 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "A model is only as good as its validation"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "LE SURFIT¬†: LA G√âNOMIQUE DU CANCER DE DUKE ‚Äî QUAND LES PR√âVISIONS PARFAITES √âTAIT PARFAITEMENT FAUX",
          source: "Baggerly & Coombes 2009 | Nature Medicine | Duke scandal",
          timeline: [
            { year: "2006", text: "Duke researchers publish genomic signatures that 'perfectly' predict chemotherapy response. Lancet, Nature Medicine. C-statistics near 1.0. Clinical trials launched.", type: "normal" },
            { year: "2007-08", text: "Biostatisticians Baggerly & Coombes try to reproduce results. Find errors: mislabeled samples, wrong gene names, data inconsistencies. Report concerns.", type: "crisis" },
            { year: "2009", text: "Duke rejette les inqui√©tudes. Les essais continuent de recruter des patients. ¬´Les r√©sultats parlent d'eux-m√™mes.¬ª L'enqu√™te interne ne r√©v√®le aucun probl√®me.", type: "crisis" },
            { year: "2010", text: "NCI pauses trials. External audit confirms systematic errors. Lead researcher Potti found to have fabricated credentials. Trials terminated. Patients harmed.", type: "crisis" },
            { year: "Root Cause", text: "Models were overfit: trained and 'validated' on same data with errors. 'Perfect' discrimination was data artifacts, not real signal. No independent validation.", type: "revelation" },
            { year: "Lesson", text: "High apparent performance is a RED FLAG without external validation. Development data can memorize noise. Overfitting looks like success ‚Äî until real-world deployment.", type: "revelation" }
          ],
          realData: {
            endpoint: "Chemotherapy response",
            claimed: "C-statistic ~0.90-1.0",
            actual: "Erreurs de bruit et de donn√©es",
            harm: "Patients enrolled in trials based on fabricated models"
          },
          hook: "THE HOOK: The Duke researchers had 'perfect' predictions. C-statistics near 1.0. Publications in top journals. Clinical trials. The only problem? The models were completely wrong. Overfitting and data errors masqueraded as breakthrough science. This is why validation isn't optional ‚Äî it's the only thing that matters."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è KEY INSIGHT: Development performance is meaningless. A model can achieve C = 0.99 on development data by memorizing noise. Only EXTERNAL validation ‚Äî testing on completely new data ‚Äî reveals true performance. If someone shows you only development metrics, you know nothing about whether the model works."
        }
      },
      {
        type: 'content',
        content: {
          title: "Le PICOT des mod√®les pronostiques",
          sections: [
            {
              heading: "P ‚Äî Population:",
              text: "√Ä qui s'adresse ce mod√®le¬†? D√©finir les crit√®res d‚Äôinclusion/exclusion. Le mod√®le s'applique UNIQUEMENT √† des patients similaires. Un mod√®le pour les patients en soins intensifs ne s'applique pas aux patients ambulatoires."
            },
            {
              heading: "I ‚Äî Index (Predictors):",
              text: "Quelles informations entrent dans le mod√®le¬†? D√©mographie, laboratoires, imagerie, g√©nomique ? Tous les pr√©dicteurs doivent √™tre disponibles au moment de la pr√©diction."
            },
            {
              heading: "C ‚Äî Comparator (Alternative Models):",
              text: "What are we comparing to? Existing models? Clinical judgment? No model? New models should IMPROVE on existing options."
            },
            {
              heading: "O ‚Äî Outcome:",
              text: "Que pr√©disons-nous¬†? La mort? R√©admission ? Progression de la maladie ? Doit √™tre cliniquement significatif, objectivement mesurable et important pour les patients/cliniciens."
            },
            {
              heading: "T ‚Äî Time Horizon:",
              text: "QUAND pr√©disons-nous¬†? Mortalit√© √† 30 jours ? Survie √† 5 ans ? Un risque √† 10 ans ? L'horizon temporel change tout¬†: les pr√©dicteurs, les performances et l'utilit√© clinique."
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "LA M√âTHODE¬†: √âTAPES DE D√âVELOPPEMENT DU MOD√àLE",
          title: "Building a Prognostic Model",
          sections: [
            {
              heading: "1. Assemble the Cohort:",
              text: "‚Ä¢ Cohorte initiale avec un point de d√©part clair ‚Ä¢ Taille d'√©chantillon ad√©quate (‚â•10 √©v√©nements par pr√©dicteur, de pr√©f√©rence ‚â•20) ‚Ä¢ Suivi complet sur un horizon temporel ‚Ä¢ Repr√©sentatif de la population cible"
            },
            {
              heading: "2. Select Predictors:",
              text: "‚Ä¢ Bas√© sur des preuves ant√©rieures et non sur une s√©lection bas√©e sur les donn√©es ‚Ä¢ Disponible au moment de la pr√©diction (aucune information future) ‚Ä¢ Mesur√© de mani√®re fiable et coh√©rente ‚Ä¢ G√©rer les donn√©es manquantes AVANT mod√©lisation"
            },
            {
              heading: "3. Choose the Model Type:",
              text: "‚Ä¢ Logistic regression: Binary outcomes at fixed time\n‚Ä¢ Cox regression: Time-to-event data\n‚Ä¢ Machine learning: Flexible but prone to overfitting\n‚Ä¢ Simpler models often generalize better"
            },
            {
              heading: "4. Fit the Model:",
              text: "‚Ä¢ Pr√©-sp√©cifier la strat√©gie de mod√©lisation ‚Ä¢ Utiliser la p√©nalisation (LASSO, ridge) si plusieurs pr√©dicteurs ‚Ä¢ V√©rifier les hypoth√®ses (lin√©arit√©, al√©as proportionnels) ‚Ä¢ Validation interne avec bootstrap ou validation crois√©e"
            },
            {
              heading: "5. Apply Shrinkage:",
              text: "‚Ä¢ Les coefficients estim√©s sont optimistes (surajustement) ‚Ä¢ Calculer le facteur de retrait (uniforme ou p√©nalis√©) ‚Ä¢ Appliquer √† tous les coefficients avant mod√®le ¬´ final ¬ª ‚Ä¢ Cela r√©duit le surajustement"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Sample Size: The Events Per Variable Rule",
          sections: [
            {
              heading: "The Problem:",
              text: "Avec trop peu d'√©v√©nements de r√©sultat par rapport aux pr√©dicteurs, les mod√®les surajustent de mani√®re catastrophique. Ils s'adaptent au bruit, pas au signal."
            },
            {
              heading: "Traditional Rule: EPV ‚â• 10",
              items: [
                "At least 10 events per predictor variable",
                "Pour 10 pr√©dicteurs, il faut ‚â•100 √©v√©nements",
                "Minimum for stable coefficient estimates",
                "Many experts now recommend EPV ‚â• 20"
              ]
            },
            {
              heading: "Example Calculation:",
              text: "You want to develop a model with 12 predictors for 30-day mortality. Mortality rate is 5%. For EPV=10: need 120 events. At 5% rate: need 120/0.05 = 2,400 patients. For EPV=20: need 4,800 patients."
            },
            {
              heading: "When EPV Is Low:",
              items: [
                "Use penalization (LASSO, ridge regression)",
                "Reduce number of predictors (combine, eliminate)",
                "Consider simpler models",
                "Be very skeptical of apparent performance"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "PLONG√âE PROFONDE¬†: M√âTHODES DE P√âNALISATION",
          title: "LASSO, Ridge, and Elastic Net Explained",
          sections: [
            {
              heading: "The Problem Penalization Solves:",
              text: "La r√©gression standard trouve les coefficients qui correspondent le mieux aux donn√©es d'entra√Ænement. Mais ¬´ meilleur ajustement ¬ª signifie souvent ¬´ bruit de surajustement ¬ª. La p√©nalisation ajoute un CO√õT pour les coefficients √©lev√©s, obligeant le mod√®le √† trouver des solutions plus simples."
            },
            {
              heading: "Ridge Regression (L2 Penalty):",
              text: "‚Ä¢ Adds penalty = Œª √ó Œ£(Œ≤¬≤) ‚Äî sum of squared coefficients\n‚Ä¢ SHRINKS all coefficients toward zero (but never exactly zero)\n‚Ä¢ Good when many predictors contribute small effects\n‚Ä¢ Handles correlated predictors well\n‚Ä¢ Œª controls shrinkage strength: higher Œª = more shrinkage"
            },
            {
              heading: "LASSO (L1 Penalty):",
              text: "‚Ä¢ Adds penalty = Œª √ó Œ£|Œ≤| ‚Äî sum of absolute coefficients\n‚Ä¢ SHRINKS coefficients AND sets some exactly to zero\n‚Ä¢ Performs variable SELECTION (sparse models)\n‚Ä¢ Better when few predictors are truly important\n‚Ä¢ Can be unstable with correlated predictors"
            },
            {
              heading: "Elastic Net (L1 + L2):",
              text: "‚Ä¢ Combine les deux p√©nalit√©s¬†: Œª‚ÇÅŒ£|Œ≤| + Œª‚ÇÇŒ£(Œ≤¬≤) ‚Ä¢ B√©n√©ficie des avantages des deux¬†: s√©lection ET retrait group√© ‚Ä¢ Souvent le meilleur choix par d√©faut ‚Ä¢ Deux param√®tres de r√©glage (utiliser la validation crois√©e)"
            },
            {
              heading: "Choosing Lambda (Œª):",
              text: "‚Ä¢ Use cross-validation to find optimal Œª\n‚Ä¢ Œª.min: minimizes prediction error\n‚Ä¢ Œª.1se: largest Œª within 1 SE of minimum (more parsimonious)\n‚Ä¢ Clinical prediction often uses Œª.1se for simplicity"
            },
            {
              heading: "Critical Limitation:",
              text: "Penalization REDUCES overfitting but doesn't ELIMINATE it. With EPV < 5, even LASSO cannot rescue a model. Penalization is not a substitute for adequate sample size ‚Äî it's a tool for when you have borderline-adequate data."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'penalization-choice',
          title: "Quelle m√©thode de p√©nalisation¬†?",
          situation: "Vous disposez de 200 √©v√©nements et 30 pr√©dicteurs candidats (EPV ‚âà 7). Vous pensez que seuls 5 √† 8 pr√©dicteurs comptent vraiment, mais vous ne savez pas lesquels. Certains pr√©dicteurs sont corr√©l√©s (par exemple, la TA systolique et diastolique).",
          nodes: {
            start: {
              question: "√âtant donn√© que vous pensez que peu de pr√©dicteurs sont importants mais qu'ils ont des variables corr√©l√©es, quelle m√©thode¬†?",
              branches: [
                { text: "LASSO ‚Äî I want variable selection", nextNode: "lasso_choice" },
                { text: "Ridge ‚Äî handles correlated predictors better", nextNode: "ridge_choice" },
                { text: "Elastic Net ‚Äî gets benefits of both", nextNode: "elastic_correct" }
              ]
            },
            lasso_choice: {
              type: 'outcome',
              outcome: 'partial',
              title: "LASSO has a weakness here",
              text: "LASSO effectue la s√©lection que vous souhaitez. Mais avec des pr√©dicteurs corr√©l√©s (variables BP), LASSO choisit arbitrairement L'UN et met l'autre √† z√©ro. Cela peut √™tre instable ‚Äì de petites modifications de donn√©es inversent la variable conserv√©e. Le r√©seau √©lastique g√®re mieux cela.",
              lesson: "LASSO est id√©al pour la s√©lection clairsem√©e, mais a du mal avec les pr√©dicteurs corr√©l√©s. Envisagez un r√©seau √©lastique lorsque les pr√©dicteurs sont corr√©l√©s."
            },
            ridge_choice: {
              type: 'outcome',
              outcome: 'partial',
              title: "Ridge won't give you selection",
              text: "Ridge g√®re bien les pr√©dicteurs corr√©l√©s et est tr√®s stable. Mais il conserve TOUS les 30 pr√©dicteurs (les r√©duit simplement). Si vous pensez que seuls 5 √† 8 comptent, vous aurez un mod√®le inutilement complexe. Pour une utilisation clinique, plus simple est souvent mieux.",
              lesson: "Ridge est stable mais ne simplifie pas. Lorsque vous souhaitez un mod√®le parcimonieux, vous avez besoin de L1 (LASSO) ou d'un filet √©lastique."
            },
            elastic_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Meilleur choix pour ce sc√©nario¬†!",
              text: "Le filet √©lastique combine la s√©lection de LASSO avec la stabilit√© de Ridge pour les pr√©dicteurs corr√©l√©s. Il s√©lectionnera probablement 5 √† 10 pr√©dicteurs tout en g√©rant la corr√©lation BP avec √©l√©gance. Utilisez la validation crois√©e pour ajuster √† la fois Œª‚ÇÅ et Œª‚ÇÇ (ou le param√®tre de m√©lange Œ±).",
              lesson: "En cas de doute, le filet √©lastique est souvent le choix le plus s√ªr¬†: il s'adapte aux structures de signaux clairsem√©es et denses."
            }
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'sample-size-decision',
          title: "Ce mod√®le est-il suffisamment aliment√©¬†?",
          situation: "Un article pr√©sente un nouveau mod√®le de pr√©diction de la mortalit√© pour les patients COVID-19. Ils comptent 500 patients avec 75 d√©c√®s (15% de mortalit√©). Ils ont test√© 25 pr√©dicteurs candidats et en ont s√©lectionn√© 8 pour le mod√®le final. La validation interne par bootstrap montre une statistique C de 0,82.",
          nodes: {
            start: {
              question: "Quelle est votre premi√®re pr√©occupation¬†?",
              branches: [
                { text: "EPV is low: 75 events / 8 predictors = 9.4", nextNode: "epv_correct" },
                { text: "La statistique C de 0,82 n'est pas si impressionnante", nextNode: "cstat_issue" },
                { text: "They tested 25 predictors but only used 8", nextNode: "selection_correct" }
              ]
            },
            epv_correct: {
              situation: "Correct ‚Äî EPV is below 10. But there's an even bigger problem...",
              question: "Les auteurs ont test√© 25 pr√©dicteurs candidats avant d'en s√©lectionner 8. Pourquoi est-ce le cas? probl√©matique¬†?",
              branches: [
                { text: "They wasted statistical power on non-significant predictors", nextNode: "power_wrong" },
                { text: "The effective EPV is 75/25 = 3, not 75/8", nextNode: "effective_epv_correct" }
              ]
            },
            cstat_issue: {
              type: 'outcome',
              outcome: 'partial',
              title: "La statistique C est correcte, mais ce n'est pas le probl√®me",
              text: "C = 0.82 would be good if it holds in external validation. The problem is that with low EPV and data-driven selection, this C-statistic is almost certainly OPTIMISTIC. The true external performance is probably much lower.",
              lesson: "Juger le d√©veloppement du mod√®le en fonction de la taille de l'√©chantillon et des m√©thodes, et non en fonction des mesures de performances rapport√©es."
            },
            power_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Il ne s'agit pas de ¬´¬†gaspiller de l'√©nergie¬†¬ª",
              text: "Le probl√®me n'est pas la puissance, c'est le SURAPPOINT. Lorsque vous testez 25 pr√©dicteurs sur 75 √©v√©nements, certains appara√Ætront pr√©dictifs PAR HASARD. La s√©lection de pr√©dicteurs ¬´ significatifs ¬ª capitalise sur ces d√©couvertes fortuites. Le mod√®le est construit en partie sur le bruit.",
              lesson: "Data-driven predictor selection (testing many, keeping 'significant' ones) is a major source of overfitting."
            },
            selection_correct: {
              situation: "Good catch! They tested 25 predictors with only 75 events. The effective EPV is 75/25 = 3.",
              question: "What should they have done instead?",
              branches: [
                { text: "Pre-specify 5-6 predictors based on prior evidence", nextNode: "prespecify_correct" },
                { text: "Use LASSO to select predictors automatically", nextNode: "lasso_partial" },
                { text: "Collect more data before testing any predictors", nextNode: "more_data_partial" }
              ]
            },
            effective_epv_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Exactly right!",
              text: "The effective degrees of freedom used is ALL 25 predictors that were tested, not just the 8 that were kept. EPV = 75/25 = 3, which is catastrophically low. The model is almost certainly overfit, regardless of what the bootstrap validation shows.",
              lesson: "EPV doit √™tre calcul√© sur la base de TOUS les pr√©dicteurs test√©s, pas seulement ceux du mod√®le final. La s√©lection bas√©e sur les donn√©es ne ¬´ sauvegarde ¬ª pas les degr√©s de libert√©."
            },
            prespecify_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Best practice!",
              text: "Pre-specifying a small number of predictors based on prior clinical knowledge (not this dataset) would give EPV = 75/6 ‚âà 12.5. Combined with shrinkage, this might produce a generalizable model. Data-driven selection should be avoided when EPV is limited.",
              lesson: "La pr√©-sp√©cification bas√©e sur les connaissances cliniques, et non la s√©lection bas√©e sur les donn√©es, est le fondement du d√©veloppement de mod√®les robustes."
            },
            lasso_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "LASSO helps, but doesn't fully solve the problem",
              text: "LASSO est meilleur que la s√©lection par √©tapes car il applique une p√©nalisation. Mais avec 75 √©v√©nements et 25 candidats, m√™me LASSO conservera probablement certaines variables de bruit. Vous avez toujours besoin d'une taille d'√©chantillon ad√©quate.",
              lesson: "Penalization reduces overfitting but doesn't eliminate it. When EPV is very low, no statistical technique can compensate."
            },
            more_data_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Ideal but not always possible",
              text: "More data is always better. But in an emerging pandemic, you may need to build models with what's available. The solution: use prior knowledge to select a small number of predictors, accept that initial models are preliminary, and plan for validation and updating.",
              lesson: "When data is limited, simplicity is essential. Complex models require large datasets."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A model shows C-statistic of 0.90 in development but 0.65 in external validation. The most likely explanation is:",
          options: [
            { id: 'a', text: "La population de validation externe √©tait diff√©rente (case-mix)", correct: false },
            { id: 'b', text: "Surapprentissage dans la cohorte de d√©veloppement", correct: true },
            { id: 'c', text: "Erreur de mesure dans les donn√©es externes", correct: false },
            { id: 'd', text: "Le mod√®le est en fait bien calibr√©", correct: false }
          ],
          explanation: "A drop from 0.90 to 0.65 is dramatic (Œî = 0.25). While case-mix differences can reduce discrimination, this magnitude of drop strongly suggests overfitting. The development C-statistic was inflated by fitting noise. The external validation reveals the true (much lower) performance."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: The Duke scandal happened because prestigious researchers, top journals, and major institutions all accepted 'perfect' model performance without independent validation. Overfitting doesn't look like failure ‚Äî it looks like remarkable success. High development performance should trigger SKEPTICISM, not celebration."
        }
      }
    ]
  },
  {
    id: 3,
    title: "The Performance",
    subtitle: "Discrimination & Calibration",
    principle: 2,
    estimatedTime: "45 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "La discrimination ne suffit pas"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE CALIBRATION CRISIS: FRAMINGHAM IN EUROPE ‚Äî WHEN A GOOD MODEL GAVE BAD NUMBERS",
          source: "Brindle 2003 | Heart | SCORE investigators | European populations",
          timeline: [
            { year: "1998", text: "Framingham Risk Score published. Excellent discrimination (C ~0.77). Becomes global standard for CVD risk assessment.", type: "normal" },
            { year: "2000s", text: "European countries adopt Framingham. Cardiologists calculate 10-year risks. Treatment decisions based on thresholds (e.g., >20% = high risk).", type: "normal" },
            { year: "2003", text: "Brindle et al. validate Framingham in UK population. DISCRIMINATION preserved (C similar). But CALIBRATION failed: Framingham predicted 47% more events than observed.", type: "crisis" },
            { year: "The Problem", text: "Framingham developed in US (higher CVD rates). Applied to UK (lower rates). The MODEL ranked patients correctly (discrimination) but gave WRONG PROBABILITIES (calibration).", type: "crisis" },
            { year: "Consequence", text: "Patients told '25% risk' when true risk was ~17%. Millions prescribed statins based on inflated numbers. Cost, side effects, psychological harm.", type: "crisis" },
            { year: "Solution", text: "SCORE, QRISK d√©velopp√© pour les populations europ√©ennes. Recalibrage aux taux d‚Äôincidence locaux. Le mod√®le doit correspondre √† la population.", type: "revelation" }
          ],
          realData: {
            endpoint: "10-year CVD events",
            discrimination: "C-statistic similar (0.75-0.77)",
            calibration: "Predicted 47% more events than observed",
            ratio: "Predicted/Observed = 1.47"
          },
          hook: "THE HOOK: Framingham DISCRIMINATED perfectly in Europe ‚Äî it correctly ranked who was higher vs lower risk. But it gave WRONG NUMBERS. A patient with 10% true risk was told 15%. This is the calibration problem: discrimination tells you WHO is at higher risk; calibration tells you WHAT that risk actually is."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è APER√áU CL√â¬†: Un mod√®le a deux emplois. DISCRIMINATION¬†: S√©parer les patients √† haut risque des patients √† faible risque (classement). CALIBRAGE¬†: Donnez des estimations de probabilit√© pr√©cises (nombres). Un mod√®le peut r√©ussir l‚Äôun et √©chouer l‚Äôautre. Les deux sont n√©cessaires aux d√©cisions cliniques."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE FRAMINGHAM RISK SCORE DECAY ‚Äî WHEN TIME ERODES ACCURACY",
          source: "Framingham Heart Study | Ridker 2016 | Population-level temporal drift",
          timeline: [
            { year: "1998", text: "Le Framingham Risk Score est publi√© avec une excellente pr√©cision pour pr√©dire les maladies cardiaques dans les populations am√©ricaines contemporaines. Statistique C d'environ 0,76-0,79.", type: "normal" },
            { year: "2000s", text: "Le score devient la r√©f√©rence. Des millions de prescriptions de statines sont guid√©es par les pr√©dictions de Framingham. Les directives cliniques consacrent ses seuils.", type: "normal" },
            { year: "2010s", text: "Researchers notice systematic overestimation. The model predicts more heart attacks than actually occur. Something has changed.", type: "crisis" },
            { year: "The Cause", text: "La POPULATION a √©volu√© tandis que le MOD√àLE est rest√© fig√©. L'usage des statines s'est g√©n√©ralis√©. Les taux de tabagisme ont chut√©. Le contr√¥le de la pression art√©rielle s'est am√©lior√©. Le risque de base a diminu√©.", type: "revelation" },
            { year: "2016", text: "Studies confirm Framingham systematically overestimates risk in modern populations. A model calibrated to 1998 Americans no longer fits 2016 Americans.", type: "crisis" },
            { year: "Lesson", text: "Prediction models are not timeless. As treatments improve, behaviors change, and populations evolve, even excellent models drift out of calibration. Regular recalibration is essential. <span class='lesson-gold'>THE LESSON: Models need maintenance. A prediction frozen in time will eventually mislead as the world around it changes.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "10-year cardiovascular disease risk",
            model: "Framingham Risk Score (1998 coefficients)",
            problem: "Systematic overestimation by 2010s",
            cause: "Population-level changes in baseline risk factors"
          },
          hook: "THE HOOK: The Framingham Risk Score didn't suddenly become a bad model. It was always a snapshot of 1998 America. But populations don't stand still. When statins, smoking cessation, and better blood pressure control changed baseline risk, the model's predictions drifted from reality. This is TEMPORAL CALIBRATION DRIFT ‚Äî and it affects every long-lived prediction model."
        }
      },
      {
        type: 'content',
        content: {
          title: "Discrimination¬†: la statistique C (AUC)",
          sections: [
            {
              heading: "What It Measures:",
              text: "La probabilit√© qu'un patient s√©lectionn√© au hasard AVEC le r√©sultat pr√©sente un risque pr√©dit plus √©lev√© qu'un patient s√©lectionn√© au hasard SANS le r√©sultat."
            },
            {
              heading: "Interpretation:",
              items: [
                "C = 0.50: No discrimination (coin flip)",
                "C = 0.60-0.70: Poor to modest discrimination",
                "C = 0.70-0.80: Acceptable discrimination",
                "C = 0.80-0.90: Excellent discrimination",
                "C > 0.90: Outstanding (or suspicious ‚Äî check for overfitting)"
              ]
            },
            {
              heading: "Limitations:",
              items: [
                "Ne vous indique pas si les risques pr√©dits sont CORRECT",
                "Can be high even with terrible calibration",
                "Hard to improve in well-developed clinical areas",
                "Depends on case-mix (heterogeneity of population)"
              ]
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Calibrage¬†: les chiffres sont-ils corrects¬†?",
          sections: [
            {
              heading: "What It Measures:",
              text: "Agreement between predicted probabilities and observed event rates. Among patients predicted 20% risk, do 20% actually have events?"
            },
            {
              heading: "Calibration-in-the-Large:",
              text: "Overall: Does the model predict the right NUMBER of events? If 100 events are predicted but 60 occur, the model overestimates (P/O = 1.67)."
            },
            {
              heading: "Calibration Slope:",
              items: [
                "Regress observed outcomes on predicted probabilities",
                "Ideal slope = 1.0 (perfect agreement)",
                "Slope < 1.0: Predictions too extreme (overfitting)",
                "Slope > 1.0: Predictions too conservative"
              ]
            },
            {
              heading: "Calibration Plot:",
              items: [
                "X-axis: Predicted probability (deciles or smooth)",
                "Y-axis: Observed event rate",
                "Perfect calibration: Points on 45-degree line",
                "Le graphique INDISPENSABLE pour la validation du mod√®le"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "LA M√âTHODE¬†: LECTURE D'UN TRAC√â DE CALIBRAGE",
          title: "Patterns and What They Mean",
          sections: [
            {
              heading: "Perfect Calibration:",
              text: "Tous les points de la diagonale. 10 % pr√©vu ‚Üí 10 % observ√©. Pr√©dit 50¬†% ‚Üí observ√© 50¬†%. Tel est l'objectif."
            },
            {
              heading: "Overestimation (Above Diagonal):",
              text: "Predicted risks too HIGH. Model says 30% but observed is 20%. Framingham in Europe. Leads to overtreatment."
            },
            {
              heading: "Underestimation (Below Diagonal):",
              text: "Predicted risks too LOW. Model says 10% but observed is 15%. Leads to undertreatment. Patients falsely reassured."
            },
            {
              heading: "Poor Calibration Slope:",
              text: "Predictions too SPREAD OUT (slope < 1) or too NARROW (slope > 1). Low-risk too low, high-risk too high = overfitting."
            },
            {
              heading: "Recalibration:",
              text: "If discrimination is good but calibration poor, RECALIBRATE: update intercept (baseline risk) and/or slope (coefficient shrinkage) to fit local population."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'discrimination-calibration',
          title: "Discrimination vs Calibration",
          situation: "You're evaluating two ICU mortality models for your hospital.\n\nModel A: C-statistic 0.85, but predicts 40% mortality when your observed rate is 25%.\nModel B: C-statistic 0.72, but calibration is excellent (predicted/observed = 1.02).",
          nodes: {
            start: {
              question: "Quel mod√®le devriez-vous utiliser pour la communication avec les patients (en indiquant aux patients leur risque)¬†?",
              branches: [
                { text: "Model A ‚Äî better discrimination", nextNode: "model_a_comm" },
                { text: "Model B ‚Äî better calibration", nextNode: "model_b_comm_correct" }
              ]
            },
            model_a_comm: {
              type: 'outcome',
              outcome: 'danger',
              title: "Patients would get wrong numbers!",
              text: "Le mod√®le¬†A indiquerait aux patients que leur risque est de 40¬†% alors qu'il est en r√©alit√© de 25¬†%. Cela provoque une d√©tresse inutile, affecte les d√©cisions concernant un traitement agressif et induit les familles en erreur. Pour la communication, le CALIBRAGE est essentiel¬†: vous avez besoin de chiffres corrects.",
              lesson: "Patient communication requires calibrated probabilities. Telling someone '40% chance of death' when it's really 25% is harmful misinformation."
            },
            model_b_comm_correct: {
              situation: "Correct! For telling patients their risk, calibration matters most.",
              question: "Now: which model should you use to TRIAGE patients (decide who gets ICU vs step-down)?",
              branches: [
                { text: "Model A ‚Äî better discrimination for ranking patients", nextNode: "model_a_triage_correct" },
                { text: "Model B ‚Äî still need correct numbers", nextNode: "model_b_triage" }
              ]
            },
            model_a_triage_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct ‚Äî for ranking, discrimination matters!",
              text: "Triage is about ranking: who is higher risk? Model A (C=0.85) better separates sick from less-sick patients. You don't need the exact probability to rank. Model A's miscalibration doesn't affect who gets ranked higher vs lower.",
              lesson: "La t√¢che d√©termine la m√©trique¬†: le RANKING n√©cessite une discrimination. LA PROBABILIT√â a besoin d‚Äô√™tre calibr√©e. Faites correspondre la m√©trique √† la question clinique."
            },
            model_b_triage: {
              type: 'outcome',
              outcome: 'partial',
              title: "Calibration is less critical for ranking",
              text: "For triage, you're RANKING patients, not quoting probabilities. Model A separates high-risk from low-risk better (C=0.85 vs 0.72). Even though Model A's numbers are off, its RANKINGS are better. Use A for triage, B for communication.",
              lesson: "Diff√©rentes t√¢ches cliniques n√©cessitent des propri√©t√©s de mod√®le diff√©rentes. De nombreux mod√®les sont utilis√©s √† des fins multiples¬†: comprenez ce que chaque utilisation n√©cessite."
            }
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'calibration-plot-reading',
          title: "Reading Calibration Plots",
          situation: "Vous examinez une √©tude de validation. Le trac√© d'√©talonnage montre¬†: ‚Ä¢ D√©cile 1 (pr√©dit 5 %) : observ√© 8 % ‚Ä¢ D√©cile 5 (pr√©dit 25 %) : observ√© 24 % ‚Ä¢ D√©cile 10 (pr√©dit 60 %) : observ√© 45 % Les points forment une courbe qui commence EN DESSOUS de la diagonale √† faible risque et traverse AU-DESSUS de la diagonale √† risque √©lev√©.",
          nodes: {
            start: {
              question: "What pattern does this calibration plot show?",
              branches: [
                { text: "Overestimation ‚Äî predictions too high overall", nextNode: "over_wrong" },
                { text: "Poor slope ‚Äî predictions too extreme", nextNode: "slope_correct" },
                { text: "Good calibration ‚Äî points are close to diagonal", nextNode: "good_wrong" }
              ]
            },
            over_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "Look at the pattern more carefully",
              text: "At LOW predicted risk (5%), observed was HIGHER (8%) ‚Äî that's underestimation. At HIGH predicted risk (60%), observed was LOWER (45%) ‚Äî that's overestimation. The model isn't consistently over- or under-estimating; it's making predictions that are too EXTREME.",
              lesson: "Les probl√®mes d'√©talonnage se pr√©sentent sous diff√©rents mod√®les. La sur/sous-estimation uniforme diff√®re des probl√®mes de pente."
            },
            slope_correct: {
              situation: "Correct! Low predictions too low, high predictions too high = slope < 1 (overfitting). Now:",
              question: "La pente d'√©talonnage est calcul√©e √† 0,65. Comment recalibrer le mod√®le¬†?",
              branches: [
                { text: "Multiply all predicted probabilities by 0.65", nextNode: "multiply_wrong" },
                { text: "R√©duire les pr√©dictions vers la moyenne (r√©estimation avec ajustement de la pente)", nextNode: "shrink_correct" }
              ]
            },
            good_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Ces √©carts sont cliniquement significatifs¬†!",
              text: "√Ä 5¬†% pr√©vu, le taux observ√© est de 8¬†%, soit 60¬†% de plus que pr√©vu. √Ä 60¬†% pr√©vu, le taux observ√© est de 45¬†%, soit 25¬†% de moins. Pour les d√©cisions cliniques, dire √† un patient ¬´ un risque de mortalit√© de 60 % ¬ª alors qu'il est en r√©alit√© de 45 % entra√Æne un pr√©judice important. Ce ne sont pas de petits √©carts.",
              lesson: "Les √©carts d'√©talonnage qui semblent ¬´ petits ¬ª en termes absolus peuvent √™tre importants en termes relatifs et cliniquement importants."
            },
            multiply_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "That would make things worse!",
              text: "Multiplier toutes les pr√©dictions par 0,65 r√©duirait TOUTES les pr√©dictions. Mais les pr√©visions faibles sont d√©j√† trop FAIBLES. Vous devez r√©duire les pr√©dictions VERS LA MOYENNE ‚Äì abaisser les plus √©lev√©es, augmenter les plus basses. Cela n√©cessite une r√©estimation avec la contrainte de pente.",
              lesson: "Recalibrage de pente ‚â† multiplication simple. Vous vous rapprochez de la moyenne, et non de z√©ro."
            },
            shrink_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct recalibration approach!",
              text: "With slope 0.65, you need to shrink predictions toward the mean outcome rate. Mathematically: calibrated_logit = intercept + 0.65 √ó (original_logit). This pulls extreme predictions toward the center. Low-risk predictions increase; high-risk predictions decrease.",
              lesson: "Le recalibrage de la pente r√©duit les pr√©dictions vers la moyenne. Cela corrige le mod√®le de surapprentissage dans lequel le mod√®le √©tait trop confiant aux deux extr√™mes."
            }
          }
        }
      },
      {
        type: 'content',
        content: {
          title: "Communicating Uncertainty to Patients",
          sections: [
            {
              heading: "Why This Matters:",
              text: "Prognostic models ultimately serve patients. A perfectly calibrated model is useless if clinicians can't communicate its outputs clearly. Miscommunication causes as much harm as miscalibration."
            },
            {
              heading: "Phrases That Help:",
              items: [
                "\"Based on patients similar to you...\" (acknowledges model basis)",
                "\"This estimate has uncertainty ‚Äî it could be somewhat higher or lower\" (conveys CI)",
                "\\\"Il s'agit d'une probabilit√©, pas d'une certitude¬†: certains patients d√©passent les probabilit√©s\\\" (√©vite le d√©terminisme)",
                "\\\"Cela nous aide √† d√©cider ensemble, pas √† pr√©dire exactement votre avenir\\\" (partag√© prise de d√©cision)",
                "\\\"Si 100 patients comme vous √©taient suivis...\\\" (cadrage fr√©quentiel)"
              ]
            },
            {
              heading: "Phrases to Avoid:",
              items: [
                "\"You have a 73% chance of...\" (false precision)",
                "\"The computer says...\" (abdicates responsibility)",
                "\\\"Vous survivrez/ne survivrez pas\\\" (langage d√©terministe)",
                "\\\"Ne vous inqui√©tez pas des chiffres\\\" (d√©daigneux)",
                "\"This is just a rough estimate\" (undermines useful information)"
              ]
            },
            {
              heading: "Handling Uncertainty:",
              text: "When the model says 30% (95% CI: 20-45%), you might say: 'Based on similar patients, the risk is probably between 1 in 5 and 1 in 2, with our best estimate around 1 in 3. This helps us think about whether aggressive treatment is right for you.'"
            },
            {
              heading: "When Models Conflict with Gestalt:",
              text: "If clinical intuition strongly disagrees with the model, acknowledge it: 'The calculator suggests X, but based on factors it doesn't capture, I think Y is more likely. Let's discuss both perspectives.'"
            }
          ]
        }
      },
      {
        type: 'content',
        content: {
          title: "Competing Risks: The Hidden Complexity",
          sections: [
            {
              heading: "The Problem:",
              text: "L'analyse de survie standard suppose que les patients ont subi l'√©v√©nement ou sont censur√©s (perdus de vue). Mais que se passe-t-il s‚Äôils MEURENT avant que l‚Äô√©v√©nement ne se produise ? La mort ¬´ rivalise ¬ª avec le r√©sultat qui nous int√©resse."
            },
            {
              heading: "Example:",
              text: "You're predicting hip fracture in elderly patients. A patient dies of heart disease at month 6. They didn't have a hip fracture ‚Äî but they also can't have one in the future. Standard Kaplan-Meier treats them as censored, which OVERESTIMATES fracture risk in survivors."
            },
            {
              heading: "When It Matters:",
              items: [
                "Elderly populations (high competing mortality)",
                "Cancer patients (death competes with recurrence)",
                "Long time horizons (more time for competing events)",
                "Non-fatal outcomes in sick populations"
              ]
            },
            {
              heading: "Solutions:",
              items: [
                "Cause-specific hazards: Model each event separately (traditional)",
                "Subdistribution hazards (Fine-Gray): Accounts for competing risks directly",
                "Multi-state models: Explicitly model transitions between states",
                "Report cumulative incidence, not 1-KM (acknowledges competing risks)"
              ]
            },
            {
              heading: "For Reviewers:",
              text: "When reading prognostic studies in elderly/sick populations with non-fatal outcomes, ask: 'How did they handle competing risks?' If the answer is 'standard Cox/KM,' the predictions may be biased upward."
            }
          ]
        }
      },
      {
        type: 'quiz',
        content: {
          question: "Un mod√®le a une statistique C de 0,75 et une pente d'√©talonnage de 0,6. Que sugg√®re ce mod√®le¬†?",
          options: [
            { id: 'a', text: "Good discrimination but predictions are too extreme (overfitting)", correct: true },
            { id: 'b', text: "Poor discrimination and poor calibration overall", correct: false },
            { id: 'c', text: "Le mod√®le sous-estime le risque pour tout le monde", correct: false },
            { id: 'd', text: "The model needs more predictors", correct: false }
          ],
          explanation: "C = 0.75 indicates acceptable discrimination. Calibration slope of 0.6 (< 1.0) means predictions are too spread out: high-risk predictions are too high, low-risk predictions are too low. This is the classic pattern of overfitting ‚Äî the model fits noise in development data, producing extreme predictions that don't generalize."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You now understand model performance dimensions AND how to communicate them. Discrimination (C-statistic) = ranking ability. Calibration = probability accuracy. Patient communication requires translating numbers into meaningful, honest conversations. Competing risks matter in elderly/sick populations with non-fatal outcomes."
        }
      }
    ]
  }
,
  {
    id: 4,
    title: "The Validation",
    subtitle: "Internal & External Testing",
    principle: 3,
    estimatedTime: "40 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Plus de pr√©dicteurs n'est pas meilleur"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE EPIC FAILURE: SEPSIS AI ‚Äî WHEN SILICON VALLEY MET REALITY",
          source: "Wong et al. JAMA Intern Med 2021 | Epic Sepsis Model | External validation",
          timeline: [
            { year: "2017", text: "Epic Systems develops machine learning model for sepsis prediction. Deployed in hundreds of hospitals. Marketing claims strong performance.", type: "normal" },
            { year: "2019", text: "Epic model in widespread clinical use. Alerts firing. Clinicians responding. Assumed to be saving lives.", type: "normal" },
            { year: "2021", text: "Wong et al. publish external validation at Michigan Medicine. C-statistic: 0.63 (poor). PPV at common threshold: 12%. Only 7% of sepsis cases detected.", type: "crisis" },
            { year: "The Gap", text: "Epic's internal 'validation' C = 0.76-0.83. Independent external: C = 0.63. The model performed FAR WORSE in real-world deployment than internal testing suggested.", type: "crisis" },
            { year: "Root Cause", text: "La validation interne a utilis√© les M√äMES sources de donn√©es et des populations similaires. Pas de v√©ritable validation externe avant le d√©ploiement. Algorithme d√©ploy√© sur la base des revendications des fournisseurs.", type: "revelation" },
            { year: "Lesson", text: "L'apprentissage automatique n'est pas magique. Les algorithmes propri√©taires n√©cessitent une validation externe IND√âPENDANTE avant le d√©ploiement clinique. Les mesures du fournisseur ne constituent pas des preuves.", type: "revelation" }
          ],
          realData: {
            endpoint: "Sepsis onset within 6 hours",
            internal: "C-statistic 0.76-0.83 (Epic's claim)",
            external: "C-statistic 0.63 (independent validation)",
            ppv: "12% at alert threshold"
          },
          hook: "THE HOOK: A proprietary algorithm was deployed in hundreds of hospitals based on vendor-provided metrics. Independent validation revealed it barely worked. Patients received thousands of false alerts while 93% of actual sepsis cases were missed. This is why external validation by INDEPENDENT researchers is essential."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚è∏Ô∏è KEY INSIGHT: Validation has levels. INTERNAL validation (same data) catches obvious overfitting. EXTERNAL validation (new data, new setting) tests generalizability. INDEPENDENT validation (different researchers) catches selective reporting and hidden biases. All three matter."
        }
      },
      {
        type: 'content',
        content: {
          title: "Types of Validation",
          sections: [
            {
              heading: "Internal Validation (Same Data):",
              items: [
                "Bootstrap: Resample with replacement, train and test many times",
                "Cross-validation: Divide data into folds, train on k-1, test on 1, rotate",
                "Split-sample: Train on 70%, test on 30% (weak, wastes data)",
                "Purpose: Estimate optimism from overfitting. MINIMUM requirement."
              ]
            },
            {
              heading: "External Validation (New Data):",
              items: [
                "TEMPORAL: Different time period, same setting",
                "GEOGRAPHIC: Different location, same time period",
                "DOMAIN: Different patient population or clinical context",
                "Purpose: Test generalizability. Required before clinical use."
              ]
            },
            {
              heading: "Independent Validation:",
              items: [
                "Different research team conducts the validation",
                "Eliminates selective reporting, hidden specification searches",
                "La SEULE validation qui teste v√©ritablement les performances dans le monde r√©el",
                "Should be required for any high-stakes model deployment"
              ]
            }
          ]
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE APACHE SCORE MISADVENTURE ‚Äî WHEN GEOGRAPHY FOOLED EVERYONE",
          source: "APACHE II validation studies | UK Intensive Care Society | Geographic transportability",
          timeline: [
            { year: "1985", text: "APACHE II is developed in US academic medical centers to predict ICU mortality. Based on 5,815 admissions across 13 hospitals. Excellent discrimination.", type: "normal" },
            { year: "Late 1980s", text: "APACHE II becomes the standard for ICU risk adjustment. Hospitals compare their outcomes to APACHE-predicted mortality. 'Better than expected' = quality marker.", type: "normal" },
            { year: "UK Adoption", text: "British hospitals adopt APACHE II for quality benchmarking. The model predicts mortality; actual deaths are compared. Nearly every UK hospital appears to outperform expectations.", type: "crisis" },
            { year: "The Problem", text: "APACHE II a √©t√© calibr√© pour les unit√©s de soins intensifs am√©ricaines des ann√©es 1980 avec une mortalit√© de base plus √©lev√©e. Les unit√©s de soins intensifs du Royaume-Uni pr√©sentaient une composition de cas diff√©rente, des seuils d'admission plus pr√©coces et de meilleurs r√©sultats. Le d√©nominateur du mod√®le √©tait erron√©.", type: "revelation" },
            { year: "False Reassurance", text: "Hospitals celebrated 'beating' APACHE predictions. But they were being compared to an irrelevant baseline. Poor performers looked adequate; adequate performers looked excellent.", type: "crisis" },
            { year: "Lesson", text: "Geographic external validation isn't just about discrimination ‚Äî it's about CALIBRATION TO LOCAL CONTEXT. A model developed in one healthcare system may systematically mispredict in another. <span class='lesson-gold'>THE LESSON: When a model makes every hospital look good, ask whether the model fits your population ‚Äî or whether you're being fooled by geographic miscalibration.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "ICU mortality",
            model: "APACHE II (US-developed)",
            problem: "Systematic overestimation in UK",
            consequence: "False reassurance about hospital quality"
          },
          hook: "THE HOOK: APACHE II was a valid model in the wrong context. Its discrimination worked fine ‚Äî it still ranked patients correctly by risk. But its CALIBRATION was anchored to American ICU mortality rates. When UK hospitals used it as a benchmark, they were measuring themselves against the wrong yardstick. Geographic validation without recalibration is a recipe for false confidence."
        }
      },
      {
        type: 'method',
        content: {
          label: "LA M√âTHODE¬†: FLUX DE TRAVAIL DE VALIDATION",
          title: "√âtapes pour une validation rigoureuse",
          sections: [
            {
              heading: "1. Obtain Completely Independent Data:",
              text: "‚Ä¢ Heure, lieu ou institution diff√©rent ‚Ä¢ Aucun chevauchement avec les donn√©es de d√©veloppement ‚Ä¢ Refl√®te la population d'utilisation pr√©vue ‚Ä¢ Nombre suffisant d'√©v√©nements pour des estimations fiables (‚â•100 √©v√©nements id√©al)"
            },
            {
              heading: "2. Apply Model EXACTLY as Developed:",
              text: "‚Ä¢ M√™mes d√©finitions de pr√©dicteurs ‚Ä¢ M√™me gestion des variables (donn√©es manquantes, seuils) ‚Ä¢ Pas de r√©ajustement, pas de modifications ‚Ä¢ Le mod√®le doit fonctionner ¬´¬†pr√™t √† l'emploi¬†¬ª"
            },
            {
              heading: "3. Assess Discrimination:",
              text: "‚Ä¢ Calculate C-statistic with 95% CI\n‚Ä¢ Compare to development performance\n‚Ä¢ Drop of >0.05 suggests poor generalizability"
            },
            {
              heading: "4. Assess Calibration:",
              text: "‚Ä¢ Calibration plot (essential)\n‚Ä¢ Calibration-in-the-large (P/O ratio)\n‚Ä¢ Calibration slope\n‚Ä¢ Hosmer-Lemeshow test (limited value)"
            },
            {
              heading: "5. Consider Updating If Needed:",
              text: "‚Ä¢ If discrimination OK but calibration poor ‚Üí recalibrate\n‚Ä¢ If discrimination poor ‚Üí model may need redevelopment\n‚Ä¢ Update intercept for new baseline rates\n‚Ä¢ Update slope if predictions too extreme"
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "DEEP DIVE: MODEL UPDATING & RECALIBRATION",
          title: "When and How to Update Existing Models",
          sections: [
            {
              heading: "Why Update Rather Than Rebuild?",
              text: "La cr√©ation de nouveaux mod√®les n√©cessite de grands ensembles de donn√©es et une validation approfondie. Si un mod√®le existant discrimine bien mais se calibre mal, UPDATING pr√©serve la structure valid√©e tout en corrigeant le calibrage. C'est souvent plus s√ªr que de repartir de z√©ro."
            },
            {
              heading: "Level 1: Intercept-Only Recalibration",
              text: "‚Ä¢ Simplest update: adjust baseline risk only\n‚Ä¢ Use when: Model systematically over/under-estimates by a constant factor\n‚Ä¢ Method: Re-estimate intercept using local event rate\n‚Ä¢ Formula: new_intercept = log(local_odds) - mean(linear_predictor)\n‚Ä¢ Preserves all coefficients; only shifts predictions up/down"
            },
            {
              heading: "Level 2: Slope + Intercept Recalibration",
              text: "‚Ä¢ Adjusts both baseline and spread of predictions\n‚Ä¢ Use when: Calibration slope ‚â† 1 (overfitting pattern)\n‚Ä¢ Method: Regress outcomes on linear predictor; use resulting intercept and slope\n‚Ä¢ Shrinks extreme predictions toward mean\n‚Ä¢ Often needed when applying models to new populations"
            },
            {
              heading: "Level 3: Model Revision (Re-estimation)",
              text: "‚Ä¢ Re-estimate some or all coefficients\n‚Ä¢ Use when: Predictor effects differ substantially in new population\n‚Ä¢ Method: Start with original coefficients as priors; update with local data\n‚Ä¢ Bayesian approaches can combine original and new evidence\n‚Ä¢ Requires larger local dataset than simple recalibration"
            },
            {
              heading: "Level 4: Model Extension",
              text: "‚Ä¢ Ajouter de nouveaux pr√©dicteurs au mod√®le existant ‚Ä¢ √Ä utiliser lorsque¬†: de nouveaux biomarqueurs ou facteurs de risque sont disponibles ‚Ä¢ M√©thode¬†: ajouter de nouveaux termes tout en pr√©servant la structure d'origine ‚Ä¢ Doit toujours valider le mod√®le √©tendu en externe ‚Ä¢ Risque¬†: les nouveaux pr√©dicteurs peuvent ajouter du bruit plut√¥t qu'un signal"
            },
            {
              heading: "Decision Framework:",
              text: "Discrimination OK + Calibration-in-large off ‚Üí Level 1\nDiscrimination OK + Slope off ‚Üí Level 2\nDiscrimination reduced + Some predictors off ‚Üí Level 3\nNew predictors available ‚Üí Consider Level 4\nDiscrimination poor across predictors ‚Üí Rebuild from scratch"
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'model-updating-decision',
          title: "Devez-vous mettre √† jour ou Reconstruire¬†?",
          situation: "Framingham Risk Score is validated at your Asian hospital. Results:\n‚Ä¢ C-statistic: 0.78 (vs 0.79 in original) ‚Äî discrimination preserved\n‚Ä¢ Predicted/Observed events: 1.85 ‚Äî model predicts 85% more events than occur\n‚Ä¢ Calibration slope: 0.95 ‚Äî close to 1.0\n\nThe model systematically overestimates, but rankings are correct.",
          nodes: {
            start: {
              question: "What type of update is most appropriate?",
              branches: [
                { text: "Rebuild a new model for Asian populations", nextNode: "rebuild_wrong" },
                { text: "Level 1: Intercept-only recalibration", nextNode: "level1_correct" },
                { text: "Level 2: Slope + intercept recalibration", nextNode: "level2_partial" }
              ]
            },
            rebuild_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Exc√®s de puissance pour ce probl√®me¬†!",
              text: "Discrimination is excellent (0.78) ‚Äî the model ranks patients correctly. The slope is 0.95 ‚Äî predictions aren't too extreme. The only problem is SYSTEMATIC overestimation (P/O = 1.85). This is exactly what intercept recalibration fixes. Rebuilding wastes the validated structure.",
              lesson: "Ne reconstruisez pas ce qui peut √™tre recalibr√©. Si la discrimination et la pente sont bonnes, l'ajustement de l'interception est suffisant."
            },
            level1_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Perfect choice!",
              text: "C-statistic preserved + slope ~1.0 + systematic over-prediction = Level 1 (intercept-only) recalibration. Simply adjust the baseline risk to reflect lower CVD rates in your Asian population. All the hard work (validated predictors, coefficients) is preserved.",
              lesson: "Le recalibrage d‚Äôinterception est puissant et simple. C'est la premi√®re chose √† essayer lorsqu'un mod√®le sur/sous-estime syst√©matiquement."
            },
            level2_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Would work, but more than needed",
              text: "Le niveau 2 ajuste √† la fois l'origine ET la pente. Mais votre pente est d√©j√† de 0,95 (essentiellement 1,0) ‚Äî les pr√©dictions ne sont pas trop extr√™mes, juste syst√©matiquement √©lev√©es. Le niveau 1 est plus simple et suffisant. Utilisez le niveau 2 lorsque la pente s'√©carte de mani√®re significative de 1,0.",
              lesson: "Faites correspondre le niveau de mise √† jour au probl√®me. Les mises √† jour plus simples sont plus robustes et n√©cessitent moins de donn√©es."
            }
          }
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'validation-type',
          title: "De quel type de validation s'agit-il¬†?",
          situation: "Classify each validation scenario by type and adequacy.",
          nodes: {
            start: {
              question: "A COVID mortality model developed in Wuhan (2020) is tested on data from Wuhan (2021). This is:",
              branches: [
                { text: "Internal validation ‚Äî same location", nextNode: "internal_wrong" },
                { text: "Temporal external validation", nextNode: "temporal_correct" }
              ]
            },
            internal_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "No ‚Äî different time = external",
              text: "M√™me s'il s'agit du m√™me h√¥pital, les donn√©es de 2021 sont EXTERNES √† une cohorte de d√©veloppement de 2020. Il s‚Äôagit d‚Äôune validation externe TEMPORELLE. La population de patients, les protocoles de traitement et les variantes virales peuvent diff√©rer.",
              lesson: "La validation externe n√©cessite des donn√©es non utilis√©es dans le d√©veloppement du mod√®le. La s√©paration temporelle le rend externe."
            },
            temporal_correct: {
              situation: "Correct! Different time period = temporal external validation.",
              question: "Le m√™me mod√®le est d√©sormais test√© √† Johns Hopkins en 2021. La statistique C passe de 0,82 √† 0,74. Quelle est votre interpr√©tation¬†?",
              branches: [
                { text: "The model failed ‚Äî drop is too large", nextNode: "drop_harsh" },
                { text: "Acceptable performance ‚Äî C 0.74 is still adequate", nextNode: "acceptable_correct" },
                { text: "Need to check calibration before judging", nextNode: "calibration_best" }
              ]
            },
            drop_harsh: {
              type: 'outcome',
              outcome: 'partial',
              title: "A drop of 0.08 is concerning but not catastrophic",
              text: "C passant de 0,82 √† 0,74 sugg√®re un surapprentissage ou des diff√©rences de population. Mais 0,74 offre toujours une discrimination raisonnable. La question cl√© est la suivante¬†: 0,74 est-il cliniquement utile¬†? Et qu‚Äôen est-il de l‚Äô√©talonnage¬†?",
              lesson: "Une certaine baisse de la statistique C est attendue lors de la validation externe. Jugez par la performance absolue, pas seulement par la baisse."
            },
            acceptable_correct: {
              type: 'outcome',
              outcome: 'partial',
              title: "C = 0.74 can be useful, but check calibration",
              text: "Discrimination of 0.74 is often adequate for clinical use. But you don't know if the model works until you check CALIBRATION. A model with C=0.74 but predicted/observed=2.0 would be dangerous.",
              lesson: "Never judge a model by C-statistic alone. Calibration failures can make discriminating models clinically harmful."
            },
            calibration_best: {
              type: 'outcome',
              outcome: 'success',
              title: "Excellent answer!",
              text: "Vous avez correctement reconnu que la statistique C √† elle seule est insuffisante. Une baisse de 0,82 √† 0,74 est tol√©rable si l‚Äô√©talonnage est maintenu. Si le mod√®le pr√©dit une mortalit√© de 30¬†% mais que Johns Hopkins en voit 15¬†%, le mod√®le est NOCIF malgr√© une discrimination acceptable.",
              lesson: "Always assess BOTH discrimination AND calibration in external validation. Many models discriminate adequately but miscalibrate badly."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A research team develops a model and tests it on a random 30% holdout of their original dataset. This is:",
          options: [
            { id: 'a', text: "Validation externe (les donn√©es n'ont pas √©t√© utilis√©es pour le d√©veloppement)", correct: false },
            { id: 'b', text: "Internal validation (same source, doesn't test generalizability)", correct: true },
            { id: 'c', text: "Independent validation (separate test)", correct: false },
            { id: 'd', text: "Aucune validation (vous ne pouvez pas valider sur des donn√©es d'exclusion)", correct: false }
          ],
          explanation: "Split-sample validation is a form of INTERNAL validation. The holdout data comes from the same time, place, and population as the development data. It does NOT test generalizability to new settings. This is the weakest form of validation ‚Äî better than nothing, but far from sufficient for clinical deployment."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è L'AVERTISSEMENT¬†: L'Epic Sepsis La d√©b√¢cle montre que les fournisseurs commercialiseront des mod√®les bas√©s sur des mesures internes. Les h√¥pitaux les d√©ploieront sans tests ind√©pendants. Les patients seront soumis √† des algorithmes qui ¬´ fonctionnent sur papier ¬ª mais √©chouent en pratique. Exigez toujours une validation externe ind√©pendante."
        }
      }
    ]
  },
  {
    id: 5,
    title: "The Scores",
    subtitle: "Clinical Prediction Rules",
    principle: 4,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "La population d√©finit la pr√©diction"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "L'HISTOIRE DE SUCC√àS¬†: CRIT√àRES DE WELLS ‚Äî QUAND LA SIMPLICIT√â A SAUV√â DES VIES",
          source: "Wells et al. 1998-2006 | Ann Intern Med | Thrombosis",
          timeline: [
            { year: "1995", text: "Philip Wells develops simple scoring system for DVT probability. Clinical signs + risk factors = points. No fancy math, no computers required.", type: "normal" },
            { year: "1997", text: "Wells DVT score validated: Low probability patients have <5% DVT prevalence. Can safely avoid imaging with negative D-dimer.", type: "revelation" },
            { year: "2000", text: "Wells PE score developed for pulmonary embolism. Similar simplicity: 7 items, integer points, three risk categories.", type: "normal" },
            { year: "2006", text: "Le score Wells PE a √©t√© largement valid√©. Combin√© avec les protocoles PERC, D-dim√®res et CTPA. Des millions de patients des services d'urgence sont stratifi√©s en fonction des risques.", type: "revelation" },
            { year: "Impact", text: "Reduced unnecessary CT scans. Reduced radiation exposure. Faster diagnoses. Lives saved by rapid identification of high-risk patients.", type: "revelation" },
            { year: "Why It Worked", text: "Simple (m√©morisable), valid√© (en externe, √† plusieurs reprises), int√©gr√© (avec parcours de diagnostic) et cliniquement utile (d√©cisions de changement).", type: "revelation" }
          ],
          realData: {
            endpoint: "DVT/PE presence",
            model: "Wells Score (DVT and PE versions)",
            discrimination: "C-statistic 0.70-0.75",
            impact: "Standard of care in emergency medicine worldwide"
          },
          hook: "THE HOOK: Wells criteria have modest C-statistics (0.70-0.75) ‚Äî not impressive by AI standards. But they're memorizable, interpretable, validated, and integrated into care pathways. They've saved more lives than any black-box algorithm. Sometimes simple wins."
        }
      },
      {
        type: 'content',
        content: {
          title: "Famous Clinical Prediction Rules",
          sections: [
            {
              heading: "Cardiovascular:",
              items: [
                "Framingham/ASCVD: 10-year CVD risk ‚Üí statin decisions",
                "CHA‚ÇÇDS‚ÇÇ-VASc: Stroke risk in AF ‚Üí anticoagulation",
                "HEART Score: Chest pain risk stratification ‚Üí discharge vs admit",
                "TIMI Risk Score: ACS prognosis ‚Üí treatment intensity"
              ]
            },
            {
              heading: "Emergency Medicine:",
              items: [
                "Wells DVT/PE: Thromboembolism probability ‚Üí testing strategy",
                "PERC: Rule out PE without testing",
                "Canadian C-Spine/CT Head: Imaging decisions after trauma",
                "Ottawa Ankle/Knee: X-ray necessity for injuries"
              ]
            },
            {
              heading: "Critical Care:",
              items: [
                "APACHE II/III/IV: ICU mortality prediction",
                "SOFA: Sequential organ failure assessment",
                "qSOFA: Quick sepsis screening (controversial)",
                "CURB-65: Pneumonia mortality ‚Üí admit vs discharge"
              ]
            },
            {
              heading: "What Makes Them Work:",
              items: [
                "Simple enough to use at bedside without calculator",
                "Validated extensively across populations",
                "Int√©gr√© aux flux de travail et aux lignes directrices cliniques",
                "Clear decision thresholds with actionable implications"
              ]
            }
          ]
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE CONTROVERSY: qSOFA ‚Äî WHEN A SCORE DIVIDED MEDICINE",
          source: "Seymour et al. JAMA 2016 | Singer et al. JAMA 2016 | Sepsis-3",
          timeline: [
            { year: "2016", text: "Sepsis-3 consensus redefines sepsis. Introduces qSOFA: 3 simple criteria (RR‚â•22, SBP‚â§100, altered mental status). 2+ points = 'think sepsis'.", type: "normal" },
            { year: "The Promise", text: "qSOFA is beautifully simple. No lab tests. Bedside assessment. Could identify sepsis risk anywhere, anytime. International uptake rapid.", type: "normal" },
            { year: "External Validation", text: "Les √©tudes affluent. Les r√©sultats sont mitig√©s. qSOFA a une SP√âCIFICIT√â (si positif, le pronostic est mauvais) mais une faible SENSIBILIT√â (manque de nombreux cas de sepsis). C ~0,65-0,70.", type: "crisis" },
            { year: "The Debate", text: "Is qSOFA for SCREENING (must be sensitive) or PROGNOSIS (can be specific)? Guidelines unclear. Emergency physicians frustrated: patients die with qSOFA=1.", type: "crisis" },
            { year: "Current Status", text: "qSOFA utile pour le pronostic (un r√©sultat positif pr√©dit la mortalit√©) mais PAS pour le d√©pistage (un r√©sultat n√©gatif n'exclut pas la septic√©mie). Diff√©rents outils pour diff√©rents objectifs.", type: "revelation" },
            { year: "Lesson", text: "A score's PURPOSE determines its required properties. Screening tools need sensitivity. Prognostic tools can trade sensitivity for specificity. Mismatched purpose = clinical failure.", type: "revelation" }
          ],
          realData: {
            endpoint: "ICU mortality, prolonged stay",
            model: "qSOFA (RR‚â•22, SBP‚â§100, AMS)",
            discrimination: "C-statistic 0.65-0.70",
            sensitivity: "45-60¬†% pour le diagnostic du sepsis"
          },
          hook: "THE HOOK: qSOFA is a great PROGNOSTIC tool ‚Äî qSOFA‚â•2 means poor prognosis. But it was marketed as a SCREENING tool, where it fails (misses half of sepsis). The lesson: Know your score's purpose. A prognostic score isn't a screening score."
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'score-selection',
          title: "Choisir le bon score",
          situation: "You're in the emergency department with a patient presenting with shortness of breath. You suspect PE. Multiple scores exist: Wells PE, Geneva, PERC, YEARS. How do you decide?",
          nodes: {
            start: {
              question: "What should guide your choice of score?",
              branches: [
                { text: "Utilisez le score avec la statistique C la plus √©lev√©e", nextNode: "cstat_wrong" },
                { text: "Utilisez le score valid√© dans votre population et int√©gr√© dans votre workflow", nextNode: "workflow_correct" },
                { text: "Use all scores and average them", nextNode: "average_wrong" }
              ]
            },
            cstat_wrong: {
              type: 'outcome',
              outcome: 'partial',
              title: "C-statistic isn't everything",
              text: "These scores have similar C-statistics (0.70-0.75). The differences are in: what populations they're validated for, how they integrate with testing (D-dimer, CTPA), and whether your institution has pathways built around them. Implementation matters more than small statistical differences.",
              lesson: "Among validated scores, choose based on local validation, workflow integration, and clinical pathway support."
            },
            workflow_correct: {
              situation: "Excellent! Your institution uses Wells + D-dimer protocol. Now: a patient has Wells score of 2 ('PE unlikely'). D-dimer is elevated. What next?",
              question: "Your action:",
              branches: [
                { text: "PE is unlikely based on Wells ‚Äî reassure and discharge", nextNode: "discharge_wrong" },
                { text: "Elevated D-dimer overrides Wells ‚Äî get CTPA", nextNode: "ctpa_correct" }
              ]
            },
            average_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Cela provoquerait le chaos¬†!",
              text: "Scores aren't designed to be averaged. They have different thresholds, different action points, and different integration with testing. PERC rules out without testing; Wells guides D-dimer interpretation. Using multiple scores without understanding their roles leads to inconsistent care.",
              lesson: "Comprenez le BUT et le CHEMIN de chaque partition. S√©lectionnez un score par voie et utilisez-le de mani√®re coh√©rente."
            },
            discharge_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Dangerous decision!",
              text: "'PE unlikely' (Wells ‚â§4) means D-dimer can rule out PE. But if D-dimer is ELEVATED in a 'PE unlikely' patient, they need imaging. The pathway is: Wells ‚Üí D-dimer ‚Üí CTPA if D-dimer positive. You can't stop at Wells when D-dimer is abnormal.",
              lesson: "Les r√®gles de pr√©diction clinique font g√©n√©ralement partie des PATHWAYS et non des d√©cisions autonomes. Suivez l'algorithme complet."
            },
            ctpa_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct clinical pathway!",
              text: "Wells 'PE unlikely' + negative D-dimer = rule out PE. Wells 'PE unlikely' + positive D-dimer = CTPA needed. The score stratifies who needs D-dimer, but the final decision combines score + D-dimer result.",
              lesson: "Les r√®gles de pr√©diction clinique se combinent souvent avec des tests de diagnostic dans les parcours. Le score seul ne prend pas la d√©cision."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "CHA‚ÇÇDS‚ÇÇ-VASc has a C-statistic of only 0.60-0.65 for predicting stroke in atrial fibrillation. Despite this modest discrimination, it's useful because:",
          options: [
            { id: 'a', text: "It perfectly calibrated in all populations", correct: false },
            { id: 'b', text: "It identifies a low-risk group (score 0-1) who can avoid anticoagulation", correct: true },
            { id: 'c', text: "C'est le seul score disponible √† cet effet", correct: false },
            { id: 'd', text: "La statistique C est mal mesur√©e", correct: false }
          ],
          explanation: "L'utilit√© clinique de CHA‚ÇÇDS‚ÇÇ-VASc ne r√©side pas globalement dans une discrimination √©lev√©e, mais dans l'identification d'un groupe √† FAIBLE RISQUE. Les patients avec un score de 0 (ou 1 chez les femmes) ont un risque d'accident vasculaire c√©r√©bral suffisamment faible pour que l'anticoagulation ne soit pas justifi√©e. La valeur du score consiste √† exclure, et non √† pr√©dire."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "CAS R√âEL¬†: L'HISTOIRE DE R√âUSSITE D'ONCOTYPE DX ‚Äî GAGNER LA CONFIANCE GR√ÇCE √Ä LA VALIDATION",
          source: "Paik et al. NEJM 2004 | TAILORx Trial 2018 | Breast cancer prognostics",
          timeline: [
            { year: "2004", text: "Oncotype DX is introduced: a 21-gene assay that generates a Recurrence Score (0-100) for early-stage, hormone receptor-positive breast cancer. Claims to predict chemotherapy benefit.", type: "normal" },
            { year: "Skepticism", text: "Les critiques exigent des preuves. Une signature g√©n√©tique issue d‚Äôune √©tude pourrait ne pas fonctionner ailleurs. Biais de publication, surajustement, manque de validation clinique¬†: toutes les pr√©occupations habituelles.", type: "crisis" },
            { year: "2006-2015", text: "Les √©tudes de validation s'accumulent. Le score est test√© sur des √©chantillons archiv√©s provenant d'essais cliniques ant√©rieurs (NSABP B-14, B-20, ATAC). R√©sultats coh√©rents entre les cohortes. La discrimination persiste.", type: "normal" },
            { year: "2018", text: "TAILORx trial results published: 10,273 women with intermediate Recurrence Scores randomized to chemotherapy vs no chemotherapy. Low scores (0-25) could safely skip chemo. Prospective validation achieved.", type: "revelation" },
            { year: "Impact", text: "Thousands of women spared unnecessary chemotherapy each year. Reduced toxicity, preserved quality of life, saved costs. A prognostic model that EARNED its place in guidelines.", type: "revelation" },
            { year: "Lesson", text: "Oncotype DX succeeded because it was validated relentlessly: retrospective cohorts, prospective trials, multiple populations. Skeptics were answered with data, not marketing. <span class='lesson-gold'>THE LESSON: Trust in prognostic models is earned through validation. Oncotype DX shows what patient-centered, evidence-based model development looks like.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "10-year distant recurrence risk",
            model: "Oncotype DX 21-gene Recurrence Score",
            discrimination: "Validated across multiple independent cohorts",
            impact: "Changed standard of care; spares thousands from unnecessary chemotherapy"
          },
          hook: "THE HOOK: When Oncotype DX was introduced, it was just another gene signature claiming to predict cancer outcomes. What made it different? Fifteen years of validation. Independent cohorts. Randomized trial evidence. A commercial test that submitted itself to the rigors of science and emerged with guidelines recommending its use. This is how prognostic models should prove themselves."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You've learned about clinical prediction rules. Key lessons: (1) Simplicity enables adoption; (2) Scores work in pathways, not isolation; (3) Purpose (screening vs prognosis) determines required properties; (4) Moderate C-statistics can still be clinically useful if they identify actionable subgroups."
        }
      }
    ]
  },
  {
    id: 6,
    title: "The Reporting",
    subtitle: "TRIPOD Guidelines",
    principle: 5,
    estimatedTime: "20 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Clinical utility trumps statistics"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE HIDDEN PROBLEM: COVID MODELS ‚Äî WHEN URGENCY TRUMPED RIGOR",
          source: "Wynants et al. BMJ 2020 (living review) | COVID prediction models",
          timeline: [
            { year: "Mar 2020", text: "Pandemic begins. Researchers worldwide rush to build COVID prognostic models. Hundreds appear on preprint servers within weeks.", type: "normal" },
            { year: "Wynants Review", text: "Un examen syst√©matique identifie 232 mod√®les de pr√©diction du COVID d'ici juillet 2020. √âvaluation √† l'aide de PROBAST (outil de risque de biais)¬†: 99¬†% √† risque √âLEV√â de biais.", type: "crisis" },
            { year: "Common Problems", text: "Small samples, data-driven variable selection, no external validation, high risk of overfitting, poorly reported methods, non-reproducible.", type: "crisis" },
            { year: "Reporting Failures", text: "Most papers didn't report: predictor definitions, missing data handling, calibration plots, sample size calculations, or model equations. Impossible to reproduce or implement.", type: "crisis" },
            { year: "Consequence", text: "Les cliniciens ne pouvaient pas utiliser les mod√®les - m√©thodes peu claires, aucun moyen de mise en ≈ìuvre, aucun outil valid√© disponible lorsqu'ils √©taient d√©sesp√©r√©s n√©cessaire.", type: "crisis" },
            { year: "Lesson", text: "Les directives de reporting TRIPOD existaient mais ont √©t√© ignor√©es dans la pr√©cipitation. La cr√©ation de rapports transparents n'est pas une surcharge bureaucratique¬†: elle est essentielle pour une utilisation clinique.", type: "revelation" }
          ],
          realData: {
            endpoint: "COVID-19 diagnosis, prognosis, mortality",
            models: "232 models reviewed",
            bias: "229/232 (99%) high risk of bias",
            issue: "Unusable due to poor reporting and methodology"
          },
          hook: "LE CROCHET¬†: 232 mod√®les de pr√©diction du COVID ont √©t√© d√©velopp√©s en 2020. 99¬†% √©taient inutilisables en raison de biais et de rapports m√©diocres. La pand√©mie avait d√©sesp√©r√©ment besoin d‚Äôoutils de pronostic ‚Äì et nous avons produit du bruit au lieu d‚Äôun signal. C'est pourquoi TRIPOD existe."
        }
      },
      {
        type: 'content',
        content: {
          title: "TRIPOD: Transparent Reporting of Prediction Models",
          sections: [
            {
              heading: "What Is TRIPOD?",
              items: [
                "Ligne directrice de reporting pour les √©tudes de mod√®les de pr√©diction (2015)",
                "22-item checklist for transparent reporting",
                "Couvre le d√©veloppement, la validation et les √©tudes combin√©es",
                "Required by many journals for publication",
                "TRIPOD-AI extension for machine learning models"
              ]
            },
            {
              heading: "Key Reporting Elements:",
              items: [
                "TITLE: Identify as development, validation, or both; name the outcome",
                "PARTICIPANTS: Eligibility criteria, settings, dates, flow diagram",
                "PREDICTORS: Definitions, assessment methods, blinding",
                "OUTCOME: Definition, assessment, timing, blinding",
                "SAMPLE SIZE: Number of participants and events, EPV",
                "MISSING DATA: How much, how handled",
                "MODEL: Full specification (coefficients, baseline risk)",
                "PERFORMANCE: Discrimination AND calibration measures"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "LA M√âTHODE¬†: LES ESSENTIELS DU TRIPOD",
          title: "What Readers Need to Implement Your Model",
          sections: [
            {
              heading: "Model Specification (Essential!):",
              text: "‚Ä¢ Tous les pr√©dicteurs avec d√©finitions ‚Ä¢ R√©gression coefficients ou poids de score ‚Ä¢ Risque de base ou interception ‚Ä¢ Instructions pour calculer la probabilit√© pr√©dite ‚Ä¢ Sans cela, votre mod√®le ne peut pas √™tre UTILIS√â"
            },
            {
              heading: "Performance Measures:",
              text: "‚Ä¢ Statistique C avec IC √† 95 % ‚Ä¢ Trac√© d'√©talonnage (MONTRER) ‚Ä¢ Calibrage dans le grand et pente ‚Ä¢ Sensibilit√©/sp√©cificit√© aux seuils pertinents ‚Ä¢ Analyse de la courbe de d√©cision pour l'utilit√© clinique"
            },
            {
              heading: "Flow Diagram:",
              text: "‚Ä¢ Combien de patients d√©pist√©s, √©ligible, analys√© ‚Ä¢ Raisons des exclusions √† chaque √©tape ‚Ä¢ Nombres avec donn√©es manquantes ‚Ä¢ Permet aux lecteurs d'√©valuer le biais de s√©lection"
            },
            {
              heading: "Missing Data:",
              text: "‚Ä¢ Proportion manquante par variable ‚Ä¢ Comment les donn√©es manquantes ont √©t√© trait√©es ‚Ä¢ Cas complet par rapport √† l'imputation ‚Ä¢ Analyse de sensibilit√© si l'imputation est utilis√©e"
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'tripod-assessment',
          title: "Ce document est-il TRIPOD Conforme¬†?",
          situation: "Vous lisez un article sur un nouveau mod√®le de pr√©vision de la mortalit√©. V√©rifiez les √©l√©ments cl√©s du TRIPOD.",
          nodes: {
            start: {
              question: "La section m√©thodes d√©crit 15 pr√©dicteurs candidats mais ne dit pas combien √©taient dans le mod√®le final. Pouvez-vous mettre en ≈ìuvre ce mod√®le¬†?",
              branches: [
                { text: "Oui¬†: la m√©thodologie est claire", nextNode: "yes_wrong" },
                { text: "No ‚Äî I don't know which predictors are included", nextNode: "no_correct" }
              ]
            },
            yes_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Vous ne pouvez pas mettre en ≈ìuvre ce que vous ne pouvez pas d√©finir¬†!",
              text: "Without knowing which predictors are in the final model and their coefficients, you CANNOT calculate predicted probabilities. The paper is incomplete. This is a TRIPOD violation: model specification must be complete.",
              lesson: "TRIPOD requires full model specification: all predictors, all coefficients, intercept/baseline. Without this, the paper is useless for clinical application."
            },
            no_correct: {
              situation: "Correct. You find the supplement with coefficients. Now: the paper reports C = 0.81 but shows no calibration plot.",
              question: "Ce rapport sur les performances est-il ad√©quat¬†?",
              branches: [
                { text: "Yes ‚Äî C-statistic tells us discrimination", nextNode: "cstat_only_wrong" },
                { text: "No ‚Äî calibration plot is essential", nextNode: "calibration_needed_correct" }
              ]
            },
            cstat_only_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Il manque la moiti√© de l'image¬†!",
              text: "C-statistic tells you DISCRIMINATION only. Without a calibration plot, you don't know if predicted probabilities are accurate. A model can have C=0.81 but overestimate risk by 50%. You need BOTH metrics.",
              lesson: "TRIPOD n√©cessite explicitement une √©valuation de l‚Äô√©talonnage. Les articles rapportant uniquement la statistique C sont incomplets. Exigez le trac√© d'√©talonnage."
            },
            calibration_needed_correct: {
              situation: "Bien¬†! Vous demandez des donn√©es d'√©talonnage suppl√©mentaires. Enfin¬†: l'article fait √©tat d'une validation interne par bootstrap mais pas de validation externe.",
              question: "Ce mod√®le est-il pr√™t pour une utilisation clinique¬†?",
              branches: [
                { text: "Yes ‚Äî bootstrap validation is rigorous", nextNode: "internal_only" },
                { text: "No ‚Äî external validation required before clinical use", nextNode: "external_needed_correct" }
              ]
            },
            internal_only: {
              type: 'outcome',
              outcome: 'partial',
              title: "Bootstrap is necessary but not sufficient",
              text: "Bootstrap s'ajuste pour plus d'optimisme dans les donn√©es de d√©veloppement. Mais il ne teste pas la G√âN√âRALIZABILIT√â avec de nouveaux param√®tres. Un mod√®le peut r√©ussir la validation d'amor√ßage et √©chouer lorsqu'il est d√©ploy√© ailleurs. Une validation externe est requise avant une utilisation clinique.",
              lesson: "Development + internal validation = MINIMUM for publication. External validation = MINIMUM for clinical implementation."
            },
            external_needed_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct judgment!",
              text: "Cet article fournit une √©tude de d√©veloppement avec validation interne. Il est publiable mais PAS pr√™t pour un d√©ploiement clinique. Les auteurs doivent explicitement indiquer la n√©cessit√© d‚Äôune validation externe et vous devez l‚Äôattendre avant d‚Äôutiliser le mod√®le cliniquement.",
              lesson: "Be explicit about what a study provides. Development without external validation = hypothesis. External validation = evidence for deployment."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A prediction model paper shows excellent discrimination (C=0.87) and perfect calibration in development data. But it doesn't provide the model equation (coefficients). This paper is:",
          options: [
            { id: 'a', text: "Complet ‚Äî la performance est l'information cl√©", correct: false },
            { id: 'b', text: "Incomplete ‚Äî readers cannot implement or validate the model", correct: true },
            { id: 'c', text: "Acceptable ‚Äî coefficients can be requested from authors", correct: false },
            { id: 'd', text: "Suffisant pour le d√©ploiement clinique", correct: false }
          ],
          explanation: "Sans coefficients, le mod√®le ne peut pas √™tre mis en ≈ìuvre, valid√© ou utilis√©. ¬´¬†Contacter les auteurs¬†¬ª n'est pas acceptable¬†: beaucoup ne r√©pondront pas et la mise en ≈ìuvre clinique n√©cessite un acc√®s imm√©diat. TR√âPIED n√©cessite une sp√©cification compl√®te du mod√®le. Cet article est fondamentalement incomplet."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: 99% of COVID prediction models were unusable. Not because prognosis was impossible ‚Äî because reporting was inadequate. TRIPOD exists to ensure that prediction models can be implemented, validated, and used. Ignoring reporting standards wastes research and harms patients."
        }
      }
    ]
  },
  {
    id: 7,
    title: "The Utility",
    subtitle: "Decision Curves & Net Benefit",
    principle: 6,
    estimatedTime: "30 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Transparency enables trust"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE MISSING PIECE: WHEN GOOD MODELS DIDN'T HELP PATIENTS",
          source: "Vickers & Elkin 2006 | Medical Decision Making | Decision curve analysis",
          timeline: [
            { year: "Classic Era", text: "Prognostic models evaluated by C-statistic and calibration. 'Good' models (C>0.75, calibrated) assumed to be clinically useful. No direct measurement of utility.", type: "normal" },
            { year: "The Problem", text: "Many models with good statistics didn't change decisions or outcomes. Example: A model that classifies everyone as high-risk has C=0.50 but perfect 'sensitivity.' Statistics can be gamed.", type: "crisis" },
            { year: "2006", text: "Vickers & Elkin pr√©sentent l'analyse de la courbe de d√©cision (DCA). Mesure directement le B√âN√âFICE NET¬†: l'utilisation du mod√®le aide-t-elle davantage de patients que de leur nuire¬†?", type: "revelation" },
            { year: "Key Insight", text: "Clinical utility depends on TREATMENT THRESHOLD ‚Äî how bad is it to miss a case vs unnecessarily treat? Different thresholds, different utility assessments.", type: "revelation" },
            { year: "Adoption", text: "DCA d√©sormais requis par de nombreuses revues. La FDA consid√®re les courbes de d√©cision pour l‚Äôapprobation des dispositifs de diagnostic. Passez de ¬´ bonnes statistiques ¬ª √† une ¬´ valeur clinique ¬ª.", type: "revelation" },
            { year: "Lesson", text: "Discrimination and calibration are necessary but not sufficient. The ultimate question: Does using this model lead to better decisions than not using it?", type: "revelation" }
          ],
          realData: {
            endpoint: "Decision-making improvement",
            method: "Net benefit calculation",
            comparison: "Model vs treat-all vs treat-none",
            impact: "Now standard in major journals"
          },
          hook: "THE HOOK: A model can have C=0.85 and perfect calibration but provide ZERO clinical benefit if it doesn't change appropriate decisions. Decision curves answer: 'Does this model help patients compared to simpler strategies?' This is the question that actually matters."
        }
      },
      {
        type: 'content',
        content: {
          title: "What Is Net Benefit?",
          sections: [
            {
              heading: "The Core Concept:",
              text: "Le b√©n√©fice net met en balance les VRAI POSITIFS (patients correctement identifi√©s pour le traitement) et les FAUX POSITIFS (patients trait√©s inutilement), ajust√©s pour tenir compte des m√©faits d'un traitement inutile."
            },
            {
              heading: "The Formula:",
              text: "Net Benefit = (True Positives / N) - (False Positives / N) √ó (threshold / (1 - threshold))"
            },
            {
              heading: "Treatment Threshold:",
              items: [
                "La probabilit√© au-dessus de laquelle vous traiteriez",
                "Reflects tradeoff: harm of missing case vs harm of unnecessary treatment",
                "Low threshold (5%): treat-all may be reasonable",
                "High threshold (30%): only treat clear high-risk patients"
              ]
            },
            {
              heading: "Comparators:",
              items: [
                "TREAT ALL: Give treatment to everyone (net benefit = outcome rate - FP penalty)",
                "TREAT NONE: Give treatment to no one (net benefit = 0)",
                "MODEL: Use model to select patients (should beat both alternatives)"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "LA M√âTHODE¬†: LECTURE D'UNE COURBE DE D√âCISION",
          title: "How to Interpret Decision Curve Analysis",
          sections: [
            {
              heading: "X-Axis: Threshold Probability",
              text: "The treatment threshold ‚Äî probability above which you'd treat. Low thresholds (left) = aggressive treatment. High thresholds (right) = conservative treatment."
            },
            {
              heading: "Y-Axis: Net Benefit",
              text: "Plus haut est mieux. Repr√©sente ¬´ les vrais positifs moins les faux positifs pond√©r√©s ¬ª. Le mod√®le pr√©sentant le b√©n√©fice net le plus √©lev√© √† votre seuil est le meilleur."
            },
            {
              heading: "Key Curves:",
              text: "‚Ä¢ TREAT ALL: Usually a downward slope (more FPs as threshold rises)\n‚Ä¢ TREAT NONE: Flat line at 0\n‚Ä¢ MODEL: Should be ABOVE both treat-all and treat-none in useful threshold range"
            },
            {
              heading: "Interpretation:",
              items: [
                "Model above treat-all AND treat-none = useful",
                "Model matches treat-all = model adds nothing",
                "Model below treat-none = model causes harm",
                "Focus on CLINICALLY RELEVANT threshold range"
              ]
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'decision-curve-interpretation',
          title: "Reading a Decision Curve",
          situation: "A decision curve shows a model for predicting 30-day readmission. At threshold 0.10: Model net benefit = 0.05, Treat-all = 0.04, Treat-none = 0. At threshold 0.30: Model net benefit = 0.02, Treat-all = -0.05, Treat-none = 0.",
          nodes: {
            start: {
              question: "At threshold 0.10 (intervene if risk >10%), is the model useful?",
              branches: [
                { text: "Yes ‚Äî model has highest net benefit (0.05 > 0.04 > 0)", nextNode: "threshold10_correct" },
                { text: "Barely ‚Äî model only slightly better than treat-all", nextNode: "threshold10_partial" }
              ]
            },
            threshold10_correct: {
              situation: "Correct ‚Äî at 10% threshold, the model provides slightly more net benefit than treating everyone. Now consider threshold 0.30:",
              question: "At threshold 0.30 (intervene only if risk >30%), what's the best strategy?",
              branches: [
                { text: "Model ‚Äî net benefit 0.02 is positive", nextNode: "model30_correct" },
                { text: "Treat-none ‚Äî model benefit is tiny", nextNode: "treatnone_partial" }
              ]
            },
            threshold10_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "La marge est importante sur le plan clinique",
              text: "Net benefit 0.05 vs 0.04 is indeed small. But over thousands of patients, even small improvements accumulate. The key question: Is the difference CLINICALLY meaningful and worth the implementation effort?",
              lesson: "Small net benefit improvements can still be worthwhile at scale. But weigh against implementation costs."
            },
            model30_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct reading!",
              text: "At threshold 0.30: Model (0.02) > Treat-none (0) > Treat-all (-0.05). The model provides positive net benefit when we're conservative about intervention. Importantly, treat-all is now HARMFUL (negative net benefit) ‚Äî intervening on everyone at high threshold wastes resources on false positives.",
              lesson: "Decision curves show WHEN a model is useful. This model helps at both thresholds but especially at higher thresholds where treat-all fails."
            },
            treatnone_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "The model is still better than nothing",
              text: "Le b√©n√©fice net de 0,02 est faible mais positif. Traiter-aucun n'a aucun avantage. Si l‚Äôintervention pr√©sente des avantages significatifs √† des co√ªts acceptables, l‚Äôutilisation du mod√®le en vaut toujours la peine. Un ¬´ petit avantage ¬ª reste un avantage.",
              lesson: "Don't dismiss small positive net benefits. But do consider: Is the benefit large enough to justify implementation?"
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A model's decision curve shows it has LOWER net benefit than 'treat all' at thresholds below 15%, but HIGHER net benefit above 15%. This model:",
          options: [
            { id: 'a', text: "Is useless ‚Äî it doesn't beat treat-all at low thresholds", correct: false },
            { id: 'b', text: "Is useful for conservative decision-makers (threshold >15%) but not aggressive ones", correct: true },
            { id: 'c', text: "Has poor discrimination", correct: false },
            { id: 'd', text: "Is poorly calibrated", correct: false }
          ],
          explanation: "Different thresholds reflect different clinical philosophies. If your threshold is >15% (conservative), use the model. If your threshold is <15% (aggressive), just treat everyone ‚Äî the model doesn't help. Clinical utility is THRESHOLD-SPECIFIC."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You've learned that clinical utility matters more than statistical performance. Decision curve analysis directly measures whether a model improves decisions. A model with modest C-statistic but positive net benefit is more valuable than a 'perfect' model that doesn't change appropriate care."
        }
      }
    ]
  },
  {
    id: 8,
    title: "The Bias",
    subtitle: "PROBAST Assessment",
    principle: 1,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "A model is only as good as its validation"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE AI MIRAGE: CHEST X-RAY MODELS ‚Äî WHEN SHORTCUTS FOOLED EVERYONE",
          source: "Zech et al. PLOS Med 2018 | DeGrave et al. Nat Mach Intell 2021 | COVID CXR",
          timeline: [
            { year: "2017-18", text: "Deep learning models achieve 'radiologist-level' performance detecting pneumonia on chest X-rays. C-statistics >0.90. Major publications.", type: "normal" },
            { year: "2018", text: "Zech et al. les mod√®les d'exposition apprennent les MARQUEURS D'H√îPITAL (pas de maladie). Les performances chutent √† C ~0,60 lorsqu'elles sont test√©es sur les images de diff√©rents h√¥pitaux. Les mod√®les ont appris les cachets du d√©partement, pas la pneumonie.", type: "crisis" },
            { year: "2020", text: "COVID CXR models proliferate. Claims of 95%+ accuracy. Deployed in some hospitals without rigorous validation.", type: "normal" },
            { year: "2021", text: "DeGrave et al. show COVID models used SHORTCUTS: patient positioning (COVID patients were sicker, positioned differently), image artifacts, and laterality markers. Not actual COVID lung findings.", type: "crisis" },
            { year: "Root Cause", text: "Les donn√©es d'entra√Ænement pr√©sentaient de fausses corr√©lations. Les facteurs confondants √©taient plus faciles √† apprendre que la pathologie r√©elle. Les ¬´¬†performances¬†¬ª internes √©lev√©es √©taient une illusion.", type: "revelation" },
            { year: "Lesson", text: "Les mod√®les ML trouvent des mod√®les ‚Äì pas n√©cessairement les BONS mod√®les. La validation externe dans divers contextes est essentielle. Les ¬´ performances de l'IA ¬ª sans √©valuation des biais n'ont aucun sens.", type: "revelation" }
          ],
          realData: {
            endpoint: "Pneumonia/COVID detection",
            claimed: "C-statistic >0.90",
            external: "C-statistic ~0.60 (different hospitals)",
            mechanism: "Learned hospital markers, patient positioning ‚Äî not disease"
          },
          hook: "THE HOOK: AI models 'outperformed radiologists' ‚Äî by learning what hospital the image came from, not what disease the patient had. This is why PROBAST and systematic bias assessment exist. High numbers mean nothing if the model learned the wrong things."
        }
      },
      {
        type: 'content',
        content: {
          title: "PROBAST: Prediction Model Risk of Bias Assessment Tool",
          sections: [
            {
              heading: "What Is PROBAST?",
              items: [
                "Outil approuv√© par Cochrane pour √©valuer les biais dans les √©tudes de mod√®les de pr√©diction",
                "Assesses RISK OF BIAS and APPLICABILITY concerns",
                "20 signaling questions across 4 domains",
                "Used in systematic reviews of prognostic models"
              ]
            },
            {
              heading: "Four Domains:",
              items: [
                "1. PARTICIPANTS: Appropriate enrollment, representative population",
                "2. PREDICTORS: Defined clearly, measured consistently, available at prediction time",
                "3. OUTCOME: Defined clearly, measured accurately, appropriate time horizon",
                "4. ANALYSIS: Adequate sample size, appropriate handling of missing data, proper validation"
              ]
            },
            {
              heading: "Overall Judgment:",
              text: "HIGH risk of bias if ANY domain is high risk. Like ROBINS-I, PROBAST is intentionally strict. One fatal flaw = study is unreliable."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'probast-assessment',
          title: "PROBAST in Practice",
          situation: "You're reviewing a COVID mortality model. The study: (1) Used hospitalized patients from one NYC hospital in April 2020; (2) Predictors included 45 variables, selected by significance testing; (3) Outcome was in-hospital death, well-defined; (4) 500 patients, 150 deaths, internal validation by bootstrap only.",
          nodes: {
            start: {
              question: "Assess the PARTICIPANTS domain:",
              branches: [
                { text: "Low risk ‚Äî all hospitalized COVID patients included", nextNode: "participants_low" },
                { text: "High risk ‚Äî one hospital, peak pandemic, selection concerns", nextNode: "participants_high" }
              ]
            },
            participants_high: {
              situation: "Good judgment. Single NYC hospital during peak means: (1) severe cases overrepresented, (2) overwhelmed system, (3) unique local practices. Now assess ANALYSIS domain:",
              question: "L'√©tude a test√© 45 variables avec 150 √©v√©nements. Qu'est-ce que l'EPV¬†?",
              branches: [
                { text: "150/45 = 3.3 ‚Äî critically low, high risk of overfitting", nextNode: "epv_correct" },
                { text: "La validation Bootstrap corrige cela - risque moyen", nextNode: "bootstrap_wrong" }
              ]
            },
            participants_low: {
              type: 'outcome',
              outcome: 'partial',
              title: "Consid√©rez les probl√®mes de g√©n√©ralisabilit√©",
              text: "While all hospitalized patients were included, a single NYC hospital during peak pandemic has unique features: extreme case severity, overwhelmed resources, specific treatment protocols. External populations will differ substantially.",
              lesson: "PROBAST √©value √† la fois le BIAIS (validit√© interne) et l'APPLICABILIT√â (validit√© externe). M√™me s'il est impartial, un mod√®le peut ne pas s'appliquer ailleurs."
            },
            epv_correct: {
              situation: "Exactly! EPV of 3.3 is critically low. Now: the authors report C-statistic of 0.88 after bootstrap validation.",
              question: "Does the high C-statistic indicate a good model?",
              branches: [
                { text: "Oui - le bootstrap a √©t√© corrig√© pour l'optimisme et C est toujours √©lev√©", nextNode: "cstat_high_wrong" },
                { text: "No ‚Äî with EPV 3.3, even bootstrap can't fix overfitting; this C is likely inflated", nextNode: "cstat_skeptic_correct" }
              ]
            },
            bootstrap_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Bootstrap cannot fix inadequate sample size!",
              text: "Bootstrap estime l'OPTIMISME √† partir du surajustement des donn√©es de d√©veloppement. Mais avec un EPV de 3,3, le mod√®le s'adapte au BRUIT plut√¥t qu'au signal. Bootstrap fera preuve d'un certain optimisme mais ne peut pas r√©v√©ler que le mod√®le est fondamentalement invalide.",
              lesson: "Bootstrap corrige le surajustement connu. Il ne peut pas sauver un mod√®le avec une taille d'√©chantillon fondamentalement inad√©quate."
            },
            cstat_high_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "This C-statistic is almost certainly unreliable!",
              text: "With EPV 3.3 and 45 variables selected by significance testing, the model has absorbed massive amounts of noise. Bootstrap helps but cannot fully correct this. The true external C is likely 0.65-0.75 at best. High internal C with low EPV = red flag.",
              lesson: "When EPV is very low, internal metrics (even bootstrap-corrected) are unreliable. Only external validation reveals true performance."
            },
            cstat_skeptic_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Excellent critical appraisal!",
              text: "You correctly identified: (1) Participant concerns from single-site pandemic peak; (2) Analysis concerns from EPV 3.3; (3) Skepticism of high C despite statistical correction. This study has HIGH risk of bias in multiple domains. PROBAST overall: HIGH RISK.",
              lesson: "PROBAST requires domain-by-domain assessment. Multiple high-risk domains = study should not inform clinical practice without external validation."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A PROBAST assessment shows: Participants LOW, Predictors LOW, Outcome LOW, Analysis HIGH (inadequate sample size). The overall risk of bias is:",
          options: [
            { id: 'a', text: "Low ‚Äî 3 of 4 domains are low risk", correct: false },
            { id: 'b', text: "Medium ‚Äî mostly low with one concern", correct: false },
            { id: 'c', text: "High ‚Äî one high-risk domain makes overall high", correct: true },
            { id: 'd', text: "Unclear ‚Äî need to average the domains", correct: false }
          ],
          explanation: "Comme ROBINS-I, PROBAST utilise le principe du ¬´ maillon le plus faible ¬ª. Si QUELQUE domaine pr√©sente un risque √©lev√©, l‚Äô√©tude globale pr√©sente un risque √©lev√©. Vous ne faites pas de moyenne et ne votez pas ‚Äì un d√©faut critique invalide l'√©tude. Ceci est intentionnellement conservateur, car un mod√®le pr√©sentant un probl√®me majeur n'est pas fiable."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: The chest X-ray AI debacle shows that impressive performance numbers can be completely artifactual. Models learn whatever predicts the outcome ‚Äî including confounders, shortcuts, and spurious correlations. PROBAST systematically checks whether a model learned the RIGHT things for the RIGHT reasons."
        }
      }
    ]
  },
  {
    id: 9,
    title: "L'apprentissage automatique",
    subtitle: "ML vs Regression",
    principle: 3,
    estimatedTime: "25 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Plus de pr√©dicteurs n'est pas meilleur"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE MODEST TRUTH: ML vs LOGISTIC REGRESSION ‚Äî WHEN COMPLEXITY DIDN'T PAY",
          source: "Christodoulou et al. 2019 | J Clin Epidemiol | Systematic review",
          timeline: [
            { year: "2010s", text: "Le battage m√©diatique de l'apprentissage automatique atteint la m√©decine. Les affirmations selon lesquelles l‚Äôapprentissage profond, les for√™ts al√©atoires et les r√©seaux de neurones r√©volutionneront la pr√©diction. ¬´¬†Les statistiques traditionnelles sont obsol√®tes.¬†¬ª", type: "normal" },
            { year: "2019", text: "Christodoulou et al. systematic review: 71 studies directly comparing ML to logistic regression for clinical prediction. Same data, same outcomes.", type: "normal" },
            { year: "The Results", text: "ML outperformed logistic regression in... 24% of studies. Logistic regression outperformed ML in 10%. No significant difference in 66%. Median C-statistic difference: 0.00.", type: "revelation" },
            { year: "Why?", text: "Pour les donn√©es cliniques tabulaires de dimensionnalit√© mod√©r√©e, la r√©gression logistique capture la plupart des signaux. Les avantages du ML apparaissent avec des images, des s√©quences et des dimensions tr√®s √©lev√©es, qui ne sont pas des pr√©dicteurs cliniques typiques.", type: "revelation" },
            { year: "The Cost", text: "Les mod√®les ML sont moins interpr√©tables, plus difficiles √† mettre en ≈ìuvre, plus sujets au surajustement sur de petits ensembles de donn√©es et n√©cessitent plus de ressources informatiques. Complexit√© sans b√©n√©fice.", type: "crisis" },
            { year: "Lesson", text: "Choisissez des m√©thodes bas√©es sur le probl√®me et non sur le battage m√©diatique. Pour la plupart des t√¢ches de pr√©diction clinique, la r√©gression logistique est comp√©titive avec le ML ‚Äì et plus pratique.", type: "revelation" }
          ],
          realData: {
            endpoint: "Various clinical outcomes",
            comparison: "71 ML vs logistic regression comparisons",
            result: "Median AUC difference: 0.00",
            winner: "Aucune diff√©rence significative dans 66¬†% des √©tudes"
          },
          hook: "THE HOOK: The systematic comparison showed ML and logistic regression perform EQUALLY for most clinical prediction. ML wins in specific domains (imaging, sequences) but not for standard clinical data. Don't use complexity when simplicity works."
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE COVID SEVERITY SCORES RACE ‚Äî WHEN SPEED DEFEATED RIGOR",
          source: "Wynants et al. BMJ 2020 (revue syst√©matique vivante) | √âtude ISARIC 4C | Mod√®les de pr√©diction COVID-19",
          timeline: [
            { year: "Early 2020", text: "COVID-19 pandemic begins. Clinicians desperately need tools to predict which patients will deteriorate. Researchers worldwide rush to develop prognostic models.", type: "normal" },
            { year: "March-June 2020", text: "Plus de 100 mod√®les pronostiques COVID publi√©s en seulement quatre mois. Apprentissage automatique, r√©gression logistique, r√©seaux de neurones : toutes les m√©thodes d√©ploy√©es. Pr√©impressions des serveurs d'inondation.", type: "normal" },
            { year: "The Review", text: "Wynants et al. systematic review: Of 107 models evaluated, nearly ALL were at high risk of bias. Small samples, no external validation, overfitting to local populations, outcome data that hadn't matured.", type: "crisis" },
            { year: "Common Flaws", text: "√âchantillons non repr√©sentatifs (premiers cas de pand√©mie). V√©rification des r√©sultats lors d'une maladie aigu√´. Traitement inappropri√© des donn√©es manquantes. Aucune validation temporelle ou g√©ographique. Mod√®les adapt√©s au bruit, pas au signal.", type: "crisis" },
            { year: "The Exceptions", text: "A few models (4C Mortality Score, ISARIC) were developed properly: large datasets (tens of thousands), multiple sites, external validation across countries. These took LONGER but actually worked.", type: "revelation" },
            { year: "Lesson", text: "Urgent need doesn't justify methodological shortcuts. Most rushed COVID models were useless ‚Äî or worse, misleading. The rigorous models that took time to develop properly were the ones that actually helped. <span class='lesson-gold'>THE LESSON: In a crisis, there's enormous pressure to 'do something.' But a bad model isn't better than no model. Speed without rigor produces predictions that can't be trusted when trust matters most.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "COVID-19 mortality or deterioration",
            models: ">100 published in 4 months",
            quality: "Nearly all at high risk of bias",
            validated: "Only handful properly externally validated"
          },
          hook: "THE HOOK: The COVID pandemic was a natural experiment in rapid model development. The result? Quantity did not equal quality. Over 100 models, nearly all useless. A handful of properly developed models (4C, ISARIC) required large multinational cohorts and careful validation. There are no shortcuts to good prognostic modeling, even in an emergency."
        }
      },
      {
        type: 'content',
        content: {
          title: "When Does ML Actually Help?",
          sections: [
            {
              heading: "ML Advantages:",
              items: [
                "Donn√©es de haute dimension (g√©nomique, prot√©omique)",
                "Image data (radiology, pathology, dermatology)",
                "Sequential/temporal data (ECGs, time series)",
                "Complex non-linear interactions (rare in clinical prediction)",
                "Very large datasets (>100,000 samples)"
              ]
            },
            {
              heading: "Logistic Regression Advantages:",
              items: [
                "Interpretable coefficients",
                "Handles small samples better (with penalization)",
                "Plus facile √† mettre en ≈ìuvre et √† d√©ployer",
                "Explicit uncertainty quantification",
                "Propri√©t√©s et diagnostics bien compris"
              ]
            },
            {
              heading: "The Decision Framework:",
              text: "If your data is tabular with <50 predictors and <10,000 samples, start with penalized logistic regression. Try ML if you have specific reasons (non-linearity, interactions, high dimensions). Compare fairly (same data, same validation)."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'ml-vs-regression',
          title: "Should You Use Machine Learning?",
          situation: "You're developing a 30-day mortality model for heart failure patients. You have: 2,000 patients, 200 deaths, 25 candidate predictors (demographics, labs, vitals), structured EHR data. A colleague insists you use deep learning because it's 'state of the art.'",
          nodes: {
            start: {
              question: "Qu'est-ce que l'EPV pour un Mod√®le √† 25 pr√©dicteurs¬†?",
              branches: [
                { text: "200/25 = 8 ‚Äî marginal for any method", nextNode: "epv_marginal" },
                { text: "Beaucoup de donn√©es pour le deep learning", nextNode: "plenty_wrong" }
              ]
            },
            epv_marginal: {
              situation: "Correct ‚Äî EPV of 8 is marginal. Deep learning typically needs MORE data than logistic regression to avoid overfitting.",
              question: "√âtant donn√© les donn√©es limit√©es, quelle est votre approche¬†?",
              branches: [
                { text: "Use deep learning but with regularization", nextNode: "dl_regularize_partial" },
                { text: "Use penalized logistic regression (LASSO/ridge)", nextNode: "penalized_correct" }
              ]
            },
            plenty_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Le deep learning a besoin de PLUS de donn√©es, pas moins¬†!",
              text: "Le deep learning comporte des millions de param√®tres. Avec 2 000 patients et 200 √©v√©nements, un r√©seau neuronal sera massivement sur√©quip√©. C‚Äôest exactement le contexte dans lequel la r√©gression logistique surpasse le ML. Les contraintes de taille d'√©chantillon FAVORISENT les m√©thodes plus simples.",
              lesson: "ML/DL brille avec le Big Data. Avec des donn√©es limit√©es, les mod√®les plus simples avec moins de param√®tres g√©n√©ralisent mieux."
            },
            dl_regularize_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Regularization helps but doesn't fully solve the problem",
              text: "Vous pouvez appliquer l'abandon, la perte de poids et l'arr√™t anticip√©. Mais l‚Äôapprentissage profond avec 200 √©v√©nements est un d√©fi difficile. M√™me les r√©seaux neuronaux bien r√©gularis√©s ont du mal √† g√©rer de petits √©chantillons. La r√©gression logistique avec LASSO est susceptible de fonctionner aussi bien, voire mieux, avec moins d'effort.",
              lesson: "Regularization is essential but doesn't overcome fundamental sample size limitations for complex models."
            },
            penalized_correct: {
              situation: "Good choice! Now: Your logistic regression model achieves C = 0.78. A vendor offers a proprietary ML model claiming C = 0.82 on similar populations.",
              question: "Devriez-vous passer au mod√®le ML du fournisseur¬†?",
              branches: [
                { text: "Yes ‚Äî 0.82 > 0.78, and ML is more sophisticated", nextNode: "switch_wrong" },
                { text: "No ‚Äî demand external validation on YOUR population first", nextNode: "validation_first_correct" }
              ]
            },
            switch_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Remember Epic Sepsis!",
              text: "Vendor-reported metrics are often inflated. A 0.04 difference in C-statistic is within noise. Without validation on YOUR population, you don't know if the ML model works in your context. Plus: Can you interpret it? Debug it? Trust it?",
              lesson: "N'adoptez jamais de mod√®les bas√©s sur les r√©clamations du fournisseur. Exigez une validation ind√©pendante sur les donn√©es repr√©sentatives de votre param√®tre."
            },
            validation_first_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Evidence-based skepticism!",
              text: "Vous avez correctement demand√© une validation avant l'adoption. La diff√©rence statistique de 0,04 C (0,78 contre 0,82) est probablement du bruit. M√™me si cela est r√©el, cela ne se traduira peut-√™tre pas par une meilleure utilit√© clinique. Votre mod√®le logistique interpr√©table peut √™tre plus s√ªr et plus facile √† mettre en ≈ìuvre.",
              lesson: "Prefer simpler models unless complexity provides clear, validated, clinically meaningful benefit."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A radiology department wants to implement an AI model for detecting pneumonia on chest X-rays. The model was trained and validated at Stanford with C = 0.92. Before deploying at your community hospital, you should:",
          options: [
            { id: 'a', text: "Deploy immediately ‚Äî Stanford is a top institution", correct: false },
            { id: 'b', text: "Validate on a sample of your hospital's images first", correct: true },
            { id: 'c', text: "Attendez l'approbation de la FDA", correct: false },
            { id: 'd', text: "Use it only for patients similar to Stanford's population", correct: false }
          ],
          explanation: "Les mod√®les d'IA en radiologie sont notoirement sensibles aux protocoles d'acquisition, √† l'√©quipement, aux populations de patients et √† la qualit√© des images. Un mod√®le form√© √† Stanford a peut-√™tre appris des fonctionnalit√©s sp√©cifiques √† Stanford. La validation locale est essentielle avant le d√©ploiement ‚Äî les √©checs de l'IA √† radiographie thoracique l'ont prouv√©."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéØ PROGRESS CHECK: You've learned that ML isn't magic. For tabular clinical data, logistic regression often matches ML performance with better interpretability. ML advantages emerge with images, sequences, or very large datasets. Choose methods based on your data and problem, not hype. Always validate before deployment."
        }
      }
    ]
  },
  {
    id: 10,
    title: "The Implementation",
    subtitle: "Du mod√®le √† la pratique",
    principle: 5,
    estimatedTime: "20 min",
    slides: [
      {
        type: 'principle-display',
        content: {
          principle: "Clinical utility trumps statistics"
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "THE IMPLEMENTATION GAP: CURB-65 ‚Äî WHEN A GOOD MODEL GATHERED DUST",
          source: "Implementation science literature | Pneumonia severity scores | Clinical workflow",
          timeline: [
            { year: "2003", text: "CURB-65 published for pneumonia severity assessment. Beautifully simple: 5 items, integer points, validated. C-statistic ~0.75 for mortality.", type: "normal" },
            { year: "Development", text: "Confusion, Urea >7, Respiratory rate ‚â•30, BP low, Age ‚â•65. Score 0-1 = outpatient. Score 2 = consider admission. Score 3-5 = ICU.", type: "normal" },
            { year: "The Problem", text: "Widespread publication didn't mean widespread use. Studies showed CURB-65 used in <50% of pneumonia admissions. Clinicians continued using gestalt.", type: "crisis" },
            { year: "Barriers", text: "Non int√©gr√© au flux de travail. Aucune invite DSE. N√©cessite de rechercher des crit√®res. Cela ne semble pas n√©cessaire lorsque ¬´ je peux dire qui est malade ¬ª. Inertie clinique.", type: "crisis" },
            { year: "Solutions qui ont fonctionn√©", text: "EHR auto-calculation, mandatory documentation, clinical decision support alerts. When CURB-65 was EMBEDDED in workflow, usage increased dramatically.", type: "revelation" },
            { year: "Lesson", text: "A valid model that isn't USED is worthless. Implementation requires: EHR integration, workflow fit, clinician buy-in, and often, mandatory documentation.", type: "revelation" }
          ],
          realData: {
            endpoint: "30-day mortality in pneumonia",
            model: "CURB-65",
            discrimination: "C-statistic ~0.75",
            usage: "<50% before implementation interventions"
          },
          hook: "THE HOOK: CURB-65 was published in 2003. Twenty years later, it's still underused in many hospitals. A prediction model is only as good as its implementation. The final mile ‚Äî from validation to bedside ‚Äî is often the hardest."
        }
      },
      {
        type: 'content',
        content: {
          title: "Implementation Barriers",
          sections: [
            {
              heading: "Clinician Factors:",
              items: [
                "Awareness: Don't know the score exists",
                "Agreement: Don't believe it adds value over clinical judgment",
                "Self-efficacy: Don't know how to use it",
                "Outcome expectancy: Don't expect it to improve patient outcomes",
                "Inertia: Existing practice works 'well enough'"
              ]
            },
            {
              heading: "System Factors:",
              items: [
                "No EHR integration ‚Äî requires separate calculation",
                "Workflow disruption ‚Äî extra steps, extra time",
                "No feedback ‚Äî clinicians don't see if score helped",
                "No accountability ‚Äî no tracking of score use",
                "Alert fatigue ‚Äî if auto-calculated, may be ignored"
              ]
            },
            {
              heading: "Model Factors:",
              items: [
                "Complexity ‚Äî can't remember the criteria",
                "Exigences en mati√®re de donn√©es ‚Äî pr√©dicteurs non collect√©s syst√©matiquement",
                "Unclear thresholds ‚Äî what action for what score?",
                "Lack of local validation ‚Äî doesn't feel applicable"
              ]
            }
          ]
        }
      },
      {
        type: 'method',
        content: {
          label: "LA M√âTHODE¬†: MISE EN ≈íUVRE R√âUSSIE",
          title: "How to Get Models Into Practice",
          sections: [
            {
              heading: "1. Choose the Right Model:",
              text: "‚Ä¢ Simple enough to use (or auto-calculate)\n‚Ä¢ Validated in similar population\n‚Ä¢ Clear action thresholds\n‚Ä¢ Addresses a real clinical need"
            },
            {
              heading: "2. Integrate Into Workflow:",
              text: "‚Ä¢ Int√©gr√© au DSE (calcul automatique si possible) ‚Ä¢ D√©clenchement aux moments cliniques appropri√©s ‚Ä¢ Affichage r√©sultats l√† o√π les d√©cisions sont prises ‚Ä¢ Minimiser la saisie de donn√©es suppl√©mentaires"
            },
            {
              heading: "3. Provide Decision Support:",
              text: "‚Ä¢ Traduire le score en action recommand√©e ‚Ä¢ Expliquez la recommandation (pourquoi ce score sugg√®re cette action) ‚Ä¢ Autoriser le remplacement avec de la documentation ‚Ä¢ Ne vous contentez pas de donner un chiffre ‚Äì donnez des conseils"
            },
            {
              heading: "4. Monitor and Feedback:",
              text: "‚Ä¢ Track score usage rates\n‚Ä¢ Monitor patient outcomes\n‚Ä¢ Provide feedback to clinicians\n‚Ä¢ Iterate and improve"
            }
          ]
        }
      },
      {
        type: 'story-deep',
        content: {
          label: "REAL-WORLD CASE: THE EPIC DETERIORATION INDEX ‚Äî TECHNICALLY VALID, CLINICALLY FRUSTRATED",
          source: "Epic Systems implementation studies | Alert fatigue literature | Clinical workflow research",
          timeline: [
            { year: "Development", text: "Epic's Deterioration Index is developed to predict patient decline 6-12 hours before clinical recognition. The algorithm analyzes vital signs, lab trends, nursing assessments. Technically sophisticated.", type: "normal" },
            { year: "Deployment", text: "Les h√¥pitaux se pr√©cipitent pour mettre en ≈ìuvre l'indice de d√©t√©rioration. La promesse : une alerte pr√©coce en cas de d√©clin des patients. Les infirmi√®res et les m√©decins seront alert√©s avant que les patients ne s'√©crasent. Des vies seront sauv√©es.", type: "normal" },
            { year: "Reality Check", text: "Des √©tudes r√©v√®lent des probl√®mes. De nombreuses alertes se d√©clenchent sur des patients qui re√ßoivent D√âJ√Ä des soins appropri√©s : l‚Äôinfirmi√®re sait que le patient est malade. L'alerte ajoute du bruit, pas un signal.", type: "crisis" },
            { year: "Alert Fatigue", text: "Clinicians receive dozens of alerts daily. Most are for patients already being managed. The 'cry wolf' effect sets in: alerts are ignored, dismissed without review, treated as background noise.", type: "crisis" },
            { year: "The Gap", text: "The model WORKS ‚Äî it identifies deteriorating patients. But identification isn't the bottleneck. The question is: what can clinicians DO differently? If the patient is already on telemetry, already receiving fluids, already being watched ‚Äî the alert provides no new action.", type: "revelation" },
            { year: "Lesson", text: "A prognostic model deployed without actionability is just noise. The Deterioration Index failed not because it couldn't predict ‚Äî but because prediction without clear, novel intervention is useless at the bedside. <span class='lesson-gold'>THE LESSON: Implementation requires more than accurate prediction. It requires: actionable thresholds, novel information, clear interventions, and workflow integration. Prediction without actionability is just sophisticated interruption.</span>", type: "revelation" }
          ],
          realData: {
            endpoint: "Patient deterioration",
            model: "Epic Deterioration Index",
            problem: "Alert fatigue from non-actionable predictions",
            barrier: "Predictions often confirmed what clinicians already knew"
          },
          hook: "THE HOOK: The Epic Deterioration Index is a case study in implementation failure. The model wasn't wrong ‚Äî it successfully identified deteriorating patients. But the alerts often told clinicians what they already knew, for patients already receiving appropriate care. Prediction needs a purpose: if knowing the score doesn't change what you do, the score is just noise."
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'implementation-strategy',
          title: "Planning Implementation",
          situation: "Your hospital wants to implement a sepsis prediction model. The model requires: lactate level, vital signs, and WBC count. It outputs a probability of sepsis. You need to design the implementation.",
          nodes: {
            start: {
              question: "O√π le mod√®le doit-il se d√©clencher dans le flux de travail clinique¬†?",
              branches: [
                { text: "When a patient is admitted to any unit", nextNode: "admission_trigger" },
                { text: "When vital signs suggest possible deterioration (SIRS-like)", nextNode: "vital_trigger_correct" },
                { text: "Every 4 hours automatically for all inpatients", nextNode: "regular_trigger_partial" }
              ]
            },
            admission_trigger: {
              type: 'outcome',
              outcome: 'partial',
              title: "Consid√©rez le contexte clinique",
              text: "Admission is one trigger point, but sepsis can develop DURING hospitalization. A patient admitted for elective surgery who develops sepsis on day 3 wouldn't be captured. Consider continuous or recurrent triggering.",
              lesson: "Faites correspondre les points d√©clencheurs au moment o√π le sepsis se d√©veloppe, et pas seulement au moment o√π les patients entrent √† l'h√¥pital."
            },
            vital_trigger_correct: {
              situation: "Bon¬†: le d√©clenchement en cas de d√©t√©rioration clinique permet de capturer les nouveaux cas. Maintenant¬†: le mod√®le se d√©clenche et pr√©dit une probabilit√© de septic√©mie de 45¬†%. Que doit afficher l'alerte ?",
              question: "Alert design:",
              branches: [
                { text: "'Sepsis probability 45%' ‚Äî let clinician decide", nextNode: "probability_only_partial" },
                { text: "'Moderate sepsis risk ‚Äî consider: lactate, blood cultures, antibiotics' with order set link", nextNode: "actionable_correct" }
              ]
            },
            regular_trigger_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Beware alert fatigue!",
              text: "Le calcul toutes les 4 heures pour tous les patients hospitalis√©s g√©n√©rera un nombre √©norme d'alertes, la plupart pour les patients √† faible risque. Les cliniciens apprendront √† les ignorer (fatigue des alertes). Le d√©clenchement cibl√© est plus efficace.",
              lesson: "Implementation must balance sensitivity against clinician burden. Alert fatigue is a real implementation failure mode."
            },
            probability_only_partial: {
              type: 'outcome',
              outcome: 'partial',
              title: "Probabilities alone don't drive action",
              text: "Clinicians don't know what to DO with '45%.' Is that high? What action is warranted? Best practice: translate probability to risk category and link to specific recommended actions (orders, consults).",
              lesson: "L'aide √† la d√©cision clinique doit √™tre ACTIONNABLE. Un nombre n'est pas une aide √† la d√©cision¬†: les recommandations avec des actions li√©es le sont."
            },
            actionable_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Cela conduit √† une action appropri√©e¬†!",
              text: "Risk category + specific recommendations + order set link = actionable decision support. The clinician sees the warning, understands the risk level, knows what to do, and can act immediately. This is how models change behavior.",
              lesson: "Implementation success requires: right trigger, clear recommendation, actionable orders. Make the right thing the easy thing."
            }
          }
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A hospital implements a readmission prediction model. Alerts fire frequently, but readmission rates don't improve. The most likely explanation is:",
          options: [
            { id: 'a', text: "The model has poor discrimination", correct: false },
            { id: 'b', text: "Alerts aren't linked to effective interventions", correct: true },
            { id: 'c', text: "Le mod√®le est mal calibr√©", correct: false },
            { id: 'd', text: "Clinicians don't trust the model", correct: false }
          ],
          explanation: "La pr√©vision sans intervention efficace n'am√©liore pas les r√©sultats. Si l'alerte indique ¬´¬†risque √©lev√© de r√©admission¬†¬ª mais qu'il n'existe aucune mesure claire et efficace pour r√©duire ce risque, l'alerte est du bruit. La mise en ≈ìuvre doit lier la pr√©diction aux interventions qui fonctionnent r√©ellement."
        }
      },
      {
        type: 'principle',
        content: {
          text: "‚ö†Ô∏è THE WARNING: Most validated models never reach clinical practice. Those that do often fail to improve outcomes ‚Äî not because the model is wrong, but because implementation is poor. The final step ‚Äî embedding prediction into action ‚Äî is where many projects fail."
        }
      }
    ]
  },
  {
    id: 11,
    title: "The Capstone",
    subtitle: "Full Model Evaluation",
    principle: null,
    estimatedTime: "30 min",
    slides: [
      {
        type: 'title',
        content: {
          title: "The Capstone",
          subtitle: "Evaluating a Prognostic Model",
          text: "Apply everything you've learned to critically evaluate a real prognostic model study."
        }
      },
      {
        type: 'content',
        content: {
          title: "Capstone Exercise: The COVID Mortality Model",
          sections: [
            {
              heading: "The Study:",
              text: "Un article pr√©sente un mod√®le d'apprentissage automatique pour pr√©dire la mortalit√© due au COVID-19. Affirmations¬†:¬†¬´¬†Notre mod√®le XGBoost atteint une statistique C de 0,91 et r√©volutionnera le triage des COVID.¬†¬ª"
            },
            {
              heading: "Study Details:",
              items: [
                "Data: 3,000 hospitalized COVID patients from one NYC hospital, March-May 2020",
                "Outcome: In-hospital mortality (600 deaths, 20% mortality rate)",
                "Predictors: 150 variables extracted from EHR, 25 selected by importance ranking",
                "Validation: 5-fold cross-validation on same dataset",
                "Calibration: 'Good' (no plot shown)",
                "No external validation"
              ]
            },
            {
              heading: "Your Task:",
              text: "√âvaluez syst√©matiquement cette √©tude en utilisant les principes de ce cours."
            }
          ]
        }
      },
      {
        type: 'decision-tree',
        content: {
          id: 'capstone-evaluation',
          title: "Capstone: Full Evaluation",
          situation: "Travailler sur chaque domaine d'√©valuation pour ce mod√®le de mortalit√© COVID.",
          nodes: {
            start: {
              question: "√âTAPE 1 - TAILLE DE L'√âCHANTILLON¬†: Ils avoir 600 √©v√©nements et 25 pr√©dicteurs. Qu'est-ce que l'EPV et est-il ad√©quat ?",
              branches: [
                { text: "EPV = 600/25 = 24 ‚Äî adequate", nextNode: "epv_surface" },
                { text: "EPV = 600/150 = 4 ‚Äî they tested 150 variables", nextNode: "epv_correct" }
              ]
            },
            epv_surface: {
              type: 'outcome',
              outcome: 'partial',
              title: "Look deeper!",
              text: "They TESTED 150 variables before selecting 25. The effective degrees of freedom used is closer to 150. EPV = 600/150 = 4, which is critically low. Data-driven selection doesn't reduce overfitting ‚Äî it increases it.",
              lesson: "L'EPV doit compter TOUTES les variables test√©es, pas seulement celles retenues. La s√©lection ne vous sauve pas."
            },
            epv_correct: {
              situation: "Correct! Effective EPV is ~4, critically low. Now assess VALIDATION:",
              question: "Ils ont utilis√© une validation crois√©e 5 fois sur le m√™me ensemble de donn√©es. Est-ce ad√©quat¬†?",
              branches: [
                { text: "Yes ‚Äî cross-validation is rigorous internal validation", nextNode: "cv_inadequate" },
                { text: "No ‚Äî no external validation means unknown generalizability", nextNode: "cv_correct" }
              ]
            },
            cv_inadequate: {
              type: 'outcome',
              outcome: 'danger',
              title: "Cross-validation is internal only!",
              text: "CV 5 fois teste le surajustement mais pas la g√©n√©ralisabilit√©. Les donn√©es proviennent toujours d‚Äôun h√¥pital de New York au plus fort de la pand√©mie. Un mod√®le form√© en avril 2020 √† New York pourrait ne pas fonctionner en juillet 2020 au Texas. Une validation externe est requise.",
              lesson: "Internal validation (CV, bootstrap) estimates optimism. External validation tests generalizability. Both are needed."
            },
            cv_correct: {
              situation: "Good! Now assess CALIBRATION:",
              question: "The paper says calibration is 'good' but shows no calibration plot. Your response:",
              branches: [
                { text: "Accept it ‚Äî they're experts who evaluated calibration", nextNode: "accept_wrong" },
                { text: "Reject ‚Äî without a calibration plot, claim is unverifiable", nextNode: "reject_correct" }
              ]
            },
            accept_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Trust but verify!",
              text: "'Good calibration' without a plot is meaningless. What threshold? What method? The COVID-19 model reviews found most papers didn't properly assess calibration. No plot = no evidence.",
              lesson: "TRIPOD n√©cessite des trac√©s d'√©talonnage. Les affirmations sans preuves ne constituent pas des preuves."
            },
            reject_correct: {
              situation: "Correct ‚Äî demand the calibration plot. Now OVERALL ASSESSMENT:",
              question: "Given everything, what is your PROBAST risk of bias judgment?",
              branches: [
                { text: "Moderate ‚Äî some concerns but promising", nextNode: "moderate_wrong" },
                { text: "High ‚Äî multiple critical flaws", nextNode: "high_correct" }
              ]
            },
            moderate_wrong: {
              type: 'outcome',
              outcome: 'danger',
              title: "Too generous!",
              text: "This study has: (1) High risk participants (single site, peak pandemic); (2) High risk analysis (EPV ~4, data-driven selection, no external validation, no calibration plot). Multiple domains at high risk = overall HIGH RISK.",
              lesson: "PROBAST est intentionnellement strict. Ce mod√®le ne doit pas √©clairer la pratique clinique."
            },
            high_correct: {
              type: 'outcome',
              outcome: 'success',
              title: "Correct critical appraisal!",
              text: "You identified: critically low EPV, data-driven selection, internal-only validation, unverified calibration claim, single-site limitations. This is a HIGH risk of bias study. The C = 0.91 is likely massively optimistic. External performance is probably C = 0.65-0.75 at best.",
              lesson: "Cette √©tude repr√©sente les 99¬†% de mod√®les COVID qui √©taient inutilisables. Une bonne √©valuation critique aurait emp√™ch√© le d√©ploiement de tels mod√®les."
            }
          }
        }
      },
      {
        type: 'content',
        content: {
          title: "üéì Cours termin√©¬†: ce que vous avez appris",
          sections: [
            {
              heading: "You Can Now:",
              items: [
                "‚úì Distinguish prognostic factors from therapeutic targets",
                "‚úì Evaluate EPV and recognize overfitting risk",
                "‚úì Interpret C-statistics and calibration plots",
                "‚úì Distinguish internal from external validation",
                "‚úì Assess model bias using PROBAST",
                "‚úì Evaluate clinical prediction rules and their pathways",
                "‚úì Apply TRIPOD reporting standards",
                "‚úì Interpret decision curves and net benefit",
                "‚úì Compare ML to logistic regression appropriately",
                "‚úì Identify implementation barriers",
                "‚úì Critically appraise prognostic model studies"
              ]
            },
            {
              heading: "The Seven Principles:",
              items: [
                "1. La pr√©diction n'est pas une causalit√©",
                "2. A model is only as good as its validation",
                "3. La discrimination ne suffit pas",
                "4. Plus de pr√©dicteurs n'est pas mieux",
                "5. La population d√©finit la pr√©diction",
                "6. Clinical utility trumps statistics",
                "7. Transparency enables trust"
              ]
            }
          ]
        }
      },
      {
        type: 'quiz',
        content: {
          question: "A colleague presents a new readmission model with C = 0.82, excellent calibration, and positive net benefit across thresholds 10-30%. No external validation yet. The model should:",
          options: [
            { id: 'a', text: "Be deployed immediately ‚Äî performance is excellent", correct: false },
            { id: 'b', text: "√ätre publi√©e sous forme d'√©tude de d√©veloppement, avec validation externe requise avant d√©ploiement", correct: true },
            { id: 'c', text: "Be rejected ‚Äî no external validation means it's invalid", correct: false },
            { id: 'd', text: "Be used only for research purposes", correct: false }
          ],
          explanation: "Development + internal validation = publishable, but NOT deployable. External validation is required before clinical use. This is the appropriate staging: develop ‚Üí validate internally ‚Üí publish ‚Üí validate externally ‚Üí deploy. Skipping external validation leads to Epic Sepsis failures."
        }
      },
      {
        type: 'principle',
        content: {
          text: "üéì FINAL MASTERY: You've completed the Prognostic Reviews course. You can now evaluate prediction models rigorously, distinguishing genuine clinical value from statistical theater. Use these skills to protect patients from poorly validated algorithms and to champion models that truly improve care. Remember: every model is wrong, but some are useful. Your job is to tell the difference."
        }
      }
    ]
  }
];

// Render Functions
function renderModuleNav() {
  const nav = document.getElementById('module-nav');
  nav.innerHTML = modules.map((m, i) => `
    <button class="module-item ${i === currentModule ? 'active' : ''} ${gameState.modulesCompleted.includes(i) ? 'completed' : ''}"
            onclick="goToModule(${i})"
            aria-current="${i === currentModule ? 'true' : 'false'}">
      <div class="module-number">${gameState.modulesCompleted.includes(i) ? '‚úì' : i}</div>
      <div class="module-info">
        <div class="module-title">${m.title}</div>
        <div class="module-subtitle">${m.subtitle}${m.estimatedTime ? ` ¬∑ <span class="time-estimate">${m.estimatedTime}</span>` : ''}</div>
      </div>
    </button>
  `).join('');
}

function renderSlide() {
  const container = document.getElementById('slide-container');
  const module = modules[currentModule];
  const slide = module.slides[currentSlide];

  let html = '';

  switch(slide.type) {
    case 'title':
      html = `
        <div class="slide-title">
          <h1>${slide.content.title}</h1>
          <div class="subtitle">${slide.content.subtitle}</div>
          <p class="description">${slide.content.text}</p>
        </div>
      `;
      break;

    case 'principle-display':
      html = `
        <div class="principle-box">
          <div class="number">${module.principle !== null ? module.principle + 1 : ''}</div>
          <div class="text">"${slide.content.principle}"</div>
        </div>
      `;
      break;

    case 'principle':
      html = `
        <div class="principle-box" style="background: linear-gradient(135deg, rgba(107,70,193,0.15), rgba(30,39,97,0.1)); padding: 2rem;">
          <div class="text" style="font-size: 1.2rem; line-height: 1.6; white-space: pre-line;">${slide.content.text}</div>
        </div>
      `;
      break;

    case 'story-deep':
      html = renderStoryDeep(slide.content);
      break;

    case 'content':
      html = renderContent(slide.content);
      break;

    case 'method':
      html = renderMethod(slide.content);
      break;

    case 'decision-tree':
      html = renderDecisionTree(slide.content);
      break;

    case 'quiz':
      html = renderQuiz(slide.content);
      break;
  }

  container.innerHTML = html;
  updateNavButtons();
  updateProgress();

  // Announce slide change for screen readers
  const announcer = document.getElementById('slide-announce');
  if (announcer) {
    const module = modules[currentModule];
    announcer.textContent = `Slide ${currentSlide + 1} of ${module.slides.length}, Module: ${module.title}`;
  }
}

function renderStoryDeep(content) {
  let html = `<div class="story-deep">`;
  html += `<div class="story-label">${content.label}</div>`;
  html += `<div class="story-source">${content.source}</div>`;

  if (content.timeline) {
    html += `<div class="timeline">`;
    content.timeline.forEach(event => {
      html += `
        <div class="timeline-event ${event.type || ''}">
          <div class="timeline-year">${event.year}</div>
          <div class="timeline-text">${event.text}</div>
        </div>
      `;
    });
    html += `</div>`;
  }

  if (content.realData) {
    html += `<div class="real-data-box">`;
    html += `<h4>üìä Real Data</h4>`;
    html += `<div class="data-grid">`;
    Object.entries(content.realData).forEach(([key, value]) => {
      html += `
        <div class="data-item">
          <div class="data-label">${key}</div>
          <div class="data-value">${value}</div>
        </div>
      `;
    });
    html += `</div></div>`;
  }

  if (content.hook) {
    html += `<div class="hook-text">${content.hook}</div>`;
  }

  html += `</div>`;
  return html;
}

function renderContent(content) {
  let html = `<div class="content-box">`;
  html += `<h2>${content.title}</h2>`;

  content.sections.forEach(section => {
    html += `<div class="content-section">`;
    html += `<h3>${section.heading}</h3>`;
    if (section.items) {
      html += `<ul>`;
      section.items.forEach(item => {
        html += `<li>${item}</li>`;
      });
      html += `</ul>`;
    }
    if (section.text) {
      html += `<p>${section.text}</p>`;
    }
    html += `</div>`;
  });

  html += `</div>`;
  return html;
}

function renderMethod(content) {
  let html = `<div class="method-box">`;
  html += `<div class="method-label">${content.label}</div>`;
  html += `<h2>${content.title}</h2>`;

  content.sections.forEach(section => {
    html += `<div class="method-section">`;
    html += `<h3>${section.heading}</h3>`;
    html += `<p>${section.text}</p>`;
    html += `</div>`;
  });

  html += `</div>`;
  return html;
}

function renderDecisionTree(content) {
  const treeId = content.id;
  if (!gameState.decisionTrees[treeId]) {
    gameState.decisionTrees[treeId] = { currentNode: 'start', history: [] };
  }

  const currentNodeId = gameState.decisionTrees[treeId].currentNode;
  const currentNode = content.nodes[currentNodeId];

  let html = `<div class="decision-tree">`;
  html += `<h2>üå≥ ${content.title}</h2>`;

  if (currentNodeId === 'start') {
    html += `<div class="decision-situation">${content.situation}</div>`;
  }

  if (currentNode.type === 'outcome') {
    html += `
      <div class="decision-outcome ${currentNode.outcome}">
        <div class="outcome-title">${currentNode.title}</div>
        <div class="outcome-text">${currentNode.text}</div>
        <div class="outcome-lesson">${currentNode.lesson}</div>
      </div>
    `;
    html += `<div class="tree-controls">
      <button class="tree-btn" onclick="resetDecisionTree('${treeId}')">Try Again</button>
    </div>`;
  } else {
    if (currentNode.situation) {
      html += `<div class="decision-situation">${currentNode.situation}</div>`;
    }
    html += `<div class="decision-question">${currentNode.question}</div>`;
    html += `<div class="decision-branches">`;
    currentNode.branches.forEach((branch, i) => {
      html += `
        <button class="decision-branch" onclick="makeDecision('${treeId}', '${branch.nextNode}', '${branch.text.replace(/\\/g, '\\\\').replace(/'/g, "\\'")}')">
          ${branch.text}
        </button>
      `;
    });
    html += `</div>`;
  }

  html += `</div>`;
  return html;
}

function makeDecision(treeId, nextNode, choiceText) {
  if (!gameState.decisionTrees[treeId]) {
    gameState.decisionTrees[treeId] = { currentNode: 'start', history: [] };
  }
  gameState.decisionTrees[treeId].history.push(choiceText);
  gameState.decisionTrees[treeId].currentNode = nextNode;
  addPoints(10);
  saveProgress();
  renderSlide();
}

function resetDecisionTree(treeId) {
  gameState.decisionTrees[treeId] = { currentNode: 'start', history: [] };
  saveProgress();
  renderSlide();
}

function renderQuiz(content) {
  const quizId = `quiz_${currentModule}_${currentSlide}`;

  return `
    <div class="quiz-container">
      <div class="quiz-question">${content.question}</div>
      <div class="quiz-options" role="radiogroup" aria-label="Quiz options">
        ${content.options.map((opt, i) => `
          <button class="quiz-option" role="radio" aria-checked="false"
                  data-correct="${opt.correct}"
                  onclick="selectQuizOption(this, '${quizId}', ${opt.correct})">
            ${opt.text}
          </button>
        `).join('')}
      </div>
      <div class="quiz-feedback" id="feedback-${quizId}" role="alert" aria-live="polite">
        <p>${content.explanation}</p>
      </div>
    </div>
  `;
}

const _answeredQuizzes = new Set();

function selectQuizOption(element, quizId, isCorrect) {
  // Prevent re-answering after first answer
  if (_answeredQuizzes.has(quizId)) return;

  const container = element.closest('.quiz-container');
  const options = container.querySelectorAll('.quiz-option');
  const feedback = document.getElementById(`feedback-${quizId}`);

  options.forEach(opt => {
    opt.classList.remove('selected', 'correct', 'incorrect');
  });

  element.classList.add('selected');
  options.forEach(opt => opt.setAttribute('aria-checked', 'false'));
  element.setAttribute('aria-checked', 'true');

  if (isCorrect) {
    element.classList.add('correct');
    feedback.classList.add('show', 'correct');
    feedback.classList.remove('incorrect');
    addPoints(30);
  } else {
    element.classList.add('incorrect');
    feedback.classList.add('show', 'incorrect');
    feedback.classList.remove('correct');
    options.forEach(opt => {
      if (opt.dataset.correct === 'true') {
        opt.classList.add('correct');
      }
    });
  }

  // Lock quiz after answering
  _answeredQuizzes.add(quizId);
  options.forEach(opt => {
    opt.style.pointerEvents = 'none';
    opt.setAttribute('aria-disabled', 'true');
  });

  saveProgress();
}

// Navigation
function nextSlide() {
  const module = modules[currentModule];
  if (currentSlide < module.slides.length - 1) {
    currentSlide++;
  } else if (currentModule < modules.length - 1) {
    if (!gameState.modulesCompleted.includes(currentModule)) {
      gameState.modulesCompleted.push(currentModule);
      addPoints(100);
      checkBadges();
    }
    currentModule++;
    currentSlide = 0;
  }
  saveProgress();
  renderSlide();
  renderModuleNav();
  window.scrollTo(0, 0);
}

function prevSlide() {
  if (currentSlide > 0) {
    currentSlide--;
  } else if (currentModule > 0) {
    currentModule--;
    currentSlide = modules[currentModule].slides.length - 1;
  }
  saveProgress();
  renderSlide();
  renderModuleNav();
  window.scrollTo(0, 0);
}

function goToModule(moduleIndex) {
  currentModule = moduleIndex;
  currentSlide = 0;
  saveProgress();
  renderSlide();
  renderModuleNav();
  closeSidebar();
  window.scrollTo(0, 0);
}

function updateNavButtons() {
  const prevBtn = document.getElementById('prev-btn');
  const nextBtn = document.getElementById('next-btn');

  prevBtn.disabled = currentModule === 0 && currentSlide === 0;

  const isLastSlide = currentModule === modules.length - 1 &&
                      currentSlide === modules[currentModule].slides.length - 1;
  nextBtn.textContent = isLastSlide ? 'Complete Course' : 'Next ‚Üí';
}

function updateProgress() {
  let totalSlides = 0;
  let completedSlides = 0;

  modules.forEach((m, i) => {
    totalSlides += m.slides.length;
    if (i < currentModule) {
      completedSlides += m.slides.length;
    } else if (i === currentModule) {
      completedSlides += currentSlide;
    }
  });

  const percent = Math.round((completedSlides / totalSlides) * 100);
  document.getElementById('progress-fill').style.width = `${percent}%`;
  document.getElementById('progress-text').textContent = `${percent}% Complete`;
}

// Points and Badges
function addPoints(points) {
  gameState.points += points;
  document.getElementById('points-display').textContent = gameState.points;
}

function checkBadges() {
  const newBadges = [];

  // Story Collector: Read most case studies
  if (gameState.modulesCompleted.length >= 10 && !gameState.earnedBadges.includes('story-collector')) {
    newBadges.push('story-collector');
  }

  // Tree Navigator: Complete 15+ decision trees
  const treesCompleted = Object.keys(gameState.decisionTrees).filter(k =>
    gameState.decisionTrees[k].history && gameState.decisionTrees[k].history.length > 0
  ).length;
  if (treesCompleted >= 15 && !gameState.earnedBadges.includes('tree-navigator')) {
    newBadges.push('tree-navigator');
  }

  // Prognosis Master: Complete entire course
  if (gameState.modulesCompleted.length === 12 && !gameState.earnedBadges.includes('prognosis-master')) {
    newBadges.push('prognosis-master');
  }

  // Model Builder: Complete Module 2 (The Models)
  if (gameState.modulesCompleted.includes(2) && !gameState.earnedBadges.includes('model-builder')) {
    newBadges.push('model-builder');
  }

  // Validation Expert: Complete Module 4 (The Validation)
  if (gameState.modulesCompleted.includes(4) && !gameState.earnedBadges.includes('validation-expert')) {
    newBadges.push('validation-expert');
  }

  // Calibration Master: Complete Module 3 (The Performance)
  if (gameState.modulesCompleted.includes(3) && !gameState.earnedBadges.includes('calibration-master')) {
    newBadges.push('calibration-master');
  }

  // TRIPOD Scholar: Complete Module 6 (The Reporting)
  if (gameState.modulesCompleted.includes(6) && !gameState.earnedBadges.includes('tripod-scholar')) {
    newBadges.push('tripod-scholar');
  }

  // Decision Analyst: Complete Module 7 (The Utility)
  if (gameState.modulesCompleted.includes(7) && !gameState.earnedBadges.includes('decision-analyst')) {
    newBadges.push('decision-analyst');
  }

  // Penalization Pro: Complete penalization decision tree
  if (gameState.decisionTrees['penalization-choice'] &&
      gameState.decisionTrees['penalization-choice'].history &&
      gameState.decisionTrees['penalization-choice'].history.length > 0 &&
      !gameState.earnedBadges.includes('penalization-pro')) {
    newBadges.push('penalization-pro');
  }

  // Patient Communicator: Complete calibration-plot-reading tree (communication content)
  if (gameState.decisionTrees['calibration-plot-reading'] &&
      gameState.decisionTrees['calibration-plot-reading'].history &&
      gameState.decisionTrees['calibration-plot-reading'].history.length > 0 &&
      !gameState.earnedBadges.includes('communicator')) {
    newBadges.push('communicator');
  }

  // AI Skeptic: Complete Module 9 (ML vs Regression)
  if (gameState.modulesCompleted.includes(9) && !gameState.earnedBadges.includes('skeptic')) {
    newBadges.push('skeptic');
  }

  // Implementation Expert: Complete Module 10 (The Implementation)
  if (gameState.modulesCompleted.includes(10) && !gameState.earnedBadges.includes('implementer')) {
    newBadges.push('implementer');
  }

  newBadges.forEach(badge => {
    gameState.earnedBadges.push(badge);
    showBadgeNotification(badge);
  });

  if (newBadges.length > 0) saveProgress();
}

function showBadgeNotification(badgeId) {
  const badge = BADGES[badgeId];
  if (!badge) return;

  const notification = document.createElement('div');
  notification.className = 'badge-notification';
  notification.innerHTML = `
    <div class="badge-icon" style="background: ${badge.color}">${badge.icon}</div>
    <div class="badge-info">
      <div class="badge-earned">Badge Earned!</div>
      <div class="badge-name">${badge.name}</div>
    </div>
  `;
  document.body.appendChild(notification);

  setTimeout(() => notification.classList.add('show'), 100);
  setTimeout(() => {
    notification.classList.remove('show');
    setTimeout(() => notification.remove(), 500);
  }, 3000);
}

// Persistence
function saveProgress() {
  try {
    localStorage.setItem(STORAGE_KEY, JSON.stringify({
      currentModule,
      currentSlide,
      gameState
    }));
  } catch (e) {
    console.log('Could not save progress:', e);
  }
}

function loadProgress() {
  try {
    const saved = localStorage.getItem(STORAGE_KEY);
    if (saved) {
      const data = JSON.parse(saved);
      if (data.gameState) {
        gameState = { ...gameState, ...data.gameState };
      }
      if (typeof data.currentModule === 'number' && data.currentModule >= 0 && data.currentModule < modules.length) {
        currentModule = data.currentModule;
      }
      if (typeof data.currentSlide === 'number' && data.currentSlide >= 0) {
        currentSlide = Math.min(data.currentSlide, modules[currentModule].slides.length - 1);
      }
    }
  } catch (e) {
    console.log('Could not load progress:', e);
  }
}

// Mobile Menu
function toggleSidebar() {
  const sidebar = document.querySelector('.sidebar');
  const overlay = document.querySelector('.sidebar-overlay');
  sidebar.classList.toggle('open');
  overlay.classList.toggle('show');
}

function closeSidebar() {
  const sidebar = document.querySelector('.sidebar');
  const overlay = document.querySelector('.sidebar-overlay');
  sidebar.classList.remove('open');
  overlay.classList.remove('show');
}

// Modal utilities: close by ID, Escape key handler
function closeModalOverlay(id) {
  const el = document.getElementById(id);
  if (el) el.remove();
}

function _attachModalEscapeHandler(overlayId) {
  function handler(e) {
    if (e.key === 'Escape') {
      closeModalOverlay(overlayId);
      document.removeEventListener('keydown', handler);
    }
  }
  document.addEventListener('keydown', handler);
}

// Badges Modal
function openBadges() {
  const earnedCount = gameState.earnedBadges.length;
  const totalCount = Object.keys(BADGES).length;

  const html = `
    <div id="badges-modal-overlay" role="dialog" aria-modal="true" aria-label="Badges" style="position: fixed; inset: 0; background: rgba(0,0,0,0.5); z-index: 2000; display: flex; align-items: center; justify-content: center; padding: 1rem;">
      <div style="background: white; border-radius: 12px; max-width: 700px; max-height: 80vh; overflow-y: auto; padding: 2rem;">
        <div style="display: flex; justify-content: space-between; align-items: center; margin-bottom: 1rem;">
          <h2 style="font-family: 'Cormorant Garamond', serif; color: var(--navy);">üèÜ Badges (${earnedCount}/${totalCount})</h2>
          <button id="badges-modal-close" onclick="closeModalOverlay('badges-modal-overlay')" style="background: none; border: none; font-size: 1.5rem; cursor: pointer;" aria-label="Close badges">&times;</button>
        </div>
        <div class="badge-grid">
          ${Object.entries(BADGES).map(([id, badge]) => {
            const earned = gameState.earnedBadges.includes(id);
            return `
              <div class="badge-card ${earned ? 'earned' : 'locked'}">
                <div class="badge-icon" style="background: ${badge.color}">${badge.icon}</div>
                <div style="font-weight: 600; color: var(--navy); margin-top: 0.5rem;">${badge.name}</div>
                <div style="font-size: 0.75rem; color: var(--light-text);">${earned ? '‚úì Earned!' : badge.requirement}</div>
              </div>
            `;
          }).join('')}
        </div>
      </div>
    </div>
  `;

  document.body.insertAdjacentHTML('beforeend', html);
  const closeBtn = document.getElementById('badges-modal-close');
  if (closeBtn) closeBtn.focus();
  _attachModalEscapeHandler('badges-modal-overlay');
}

// Glossary
function openGlossary() {
  const terms = [
    { term: "Prognostic Factor", def: "A variable associated with future clinical outcomes in patients with a condition." },
    { term: "C-Statistic (AUC)", def: "Measure of discrimination; probability that a random case is ranked higher than a random non-case." },
    { term: "Calibration", def: "Agreement between predicted probabilities and observed event rates." },
    { term: "Calibration Plot", def: "Graph showing predicted vs observed probabilities across risk groups." },
    { term: "Calibration-in-the-Large", def: "Overall agreement between total predicted and observed events; expressed as P/O ratio." },
    { term: "Overfitting", def: "When a model learns noise in training data rather than true signal; causes poor generalization." },
    { term: "EPV", def: "Events Per Variable; ratio of outcome events to predictors. Should be ‚â•10, preferably ‚â•20." },
    { term: "Internal Validation", def: "Testing model on same data source (bootstrap, cross-validation)." },
    { term: "External Validation", def: "Testing model on completely independent data (different time, place, or population)." },
    { term: "Temporal Validation", def: "External validation using data from a different time period at the same site." },
    { term: "Geographic Validation", def: "External validation using data from a different location or institution." },
    { term: "TRIPOD", def: "Transparent Reporting of prediction models; 22-item reporting guideline." },
    { term: "PROBAST", def: "Prediction model Risk Of Bias Assessment Tool; evaluates bias in prediction studies." },
    { term: "Decision Curve", def: "Graph showing net benefit across treatment thresholds; assesses clinical utility." },
    { term: "Net Benefit", def: "True positives minus weighted false positives; measures clinical value of predictions." },
    { term: "Shrinkage", def: "Reducing model coefficients to correct for optimism from overfitting." },
    { term: "Calibration Slope", def: "Regression of outcomes on predictions; slope=1 is ideal, <1 indicates overfitting." },
    { term: "Clinical Prediction Rule", def: "Scoring system using clinical data to estimate probability or guide decisions." },
    { term: "Treatment Threshold", def: "Probability above which treatment is indicated; reflects benefit-harm tradeoff." },
    { term: "LASSO", def: "Least Absolute Shrinkage and Selection Operator; penalization method that shrinks coefficients and sets some to zero." },
    { term: "Ridge Regression", def: "Penalization method that shrinks all coefficients toward zero but never exactly to zero." },
    { term: "Elastic Net", def: "Penalization combining LASSO (L1) and Ridge (L2); balances selection and grouped shrinkage." },
    { term: "Recalibration", def: "Updating model intercept and/or slope to improve calibration in a new population." },
    { term: "Competing Risks", def: "When patients can experience multiple mutually exclusive events (e.g., death prevents later fracture)." },
    { term: "Subdistribution Hazard", def: "Hazard function that accounts for competing risks (Fine-Gray method)." },
    { term: "Cumulative Incidence", def: "Probability of event accounting for competing risks; preferred over 1-KM when competing events occur." },
    { term: "Prediction Interval", def: "Range of predicted probabilities expected in future similar patients; wider than confidence interval." },
    { term: "Brier Score", def: "Overall measure combining discrimination and calibration; average squared difference between predicted and observed." }
  ];

  const html = `
    <div id="glossary-modal-overlay" role="dialog" aria-modal="true" aria-label="Glossary" style="position: fixed; inset: 0; background: rgba(0,0,0,0.5); z-index: 2000; display: flex; align-items: center; justify-content: center; padding: 1rem;">
      <div style="background: white; border-radius: 12px; max-width: 600px; max-height: 80vh; overflow-y: auto; padding: 2rem;">
        <div style="display: flex; justify-content: space-between; align-items: center; margin-bottom: 1rem;">
          <h2 style="font-family: 'Cormorant Garamond', serif; color: var(--navy);">Glossary</h2>
          <button id="glossary-modal-close" onclick="closeModalOverlay('glossary-modal-overlay')" style="background: none; border: none; font-size: 1.5rem; cursor: pointer;" aria-label="Close glossary">&times;</button>
        </div>
        ${terms.map(t => `
          <div style="margin-bottom: 1rem; padding-bottom: 1rem; border-bottom: 1px solid rgba(0,0,0,0.1);">
            <strong style="color: var(--purple);">${t.term}</strong>
            <p style="margin-top: 0.25rem; color: var(--navy);">${t.def}</p>
          </div>
        `).join('')}
      </div>
    </div>
  `;

  document.body.insertAdjacentHTML('beforeend', html);
  const closeBtn = document.getElementById('glossary-modal-close');
  if (closeBtn) closeBtn.focus();
  _attachModalEscapeHandler('glossary-modal-overlay');
}

// Initialize
document.addEventListener('DOMContentLoaded', () => {
  loadProgress();
  renderModuleNav();
  renderSlide();
  document.getElementById('points-display').textContent = gameState.points;

  document.querySelector('.hamburger').addEventListener('click', toggleSidebar);
  document.querySelector('.sidebar-overlay').addEventListener('click', closeSidebar);

  document.addEventListener('keydown', (e) => {
    if (e.key === 'ArrowRight' && !e.target.matches('input, textarea, button, select, [role="button"]')) {
      nextSlide();
    } else if (e.key === 'ArrowLeft' && !e.target.matches('input, textarea, button, select, [role="button"]')) {
      prevSlide();
    }
  });
});
</script>
</body>
</html>
